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ABSTRACT 
Differential Alterations of Key Cytokine Production by 
Aflatoxin B1 and T-2 toxin in Male CD-1 Mice 
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Raviprakash R. Dugyala, Doctor of Philosophy 
Utah State University, 1995 
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Program: Toxicology 
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Aflatoxin B, and T-2 toxin are mycotoxins, which produce their 
immunotoxic effects by affecting nonspecific and acquired immunity in different 
species. The mechanisms of their immunotoxicity are still obscure. Cytokines 
are the key signaling molecules during the immune response. In this study, 
expression of macrophage-produced cytokines Interleukin-la (IL-la), tumor 
necrosis factor (TNF), and IL-6, and lymphocyte-produced cytokines IL-2, 
interferon y (IFNy), and IL-3 was measured at the mRNA and protein levels, after 
in vitro activation with rnitogens in AFB,- and T-2-toxin-exposed mice. 
Significant changes in the organ weights, especially in the mice exposed to 
a high dose of T-2 toxin, and no effect in AFB,-exposed mice were observed. 
iv 
ConA-induced production of IL-2, IFNy, and IL-3 mRNA and protein 
levels in AFB1-exposed mice showed a decrease in low dose groups (significant 
for IL-2 mRNA), but no change at other doses. However, in T-2-toxin-treated 
animals, there was a significant induction of IL-2 and IFNy mRN A in high and 
low doses and of IL-3 mRNA at the medium dose. The protein levels of IL-2 and 
IFNy did not follow the mRNA levels in high dose and the protein levels of IL-3 
were significantly increased in medium and low doses. 
Lf-'5-induced IL-la and TNF mRNA and protein levels in AFB1-exposed 
mice were suppressed at the high dose while mRNA levels of both cytokines 
were increased significantly in the low and medium doses. Low and medium 
doses of AFB1 also significantly decreased IL-lu protein levels and the high dose 
decreased IL-6 protein. In T-2 toxin-treated mice, no significant difference in 
mRNA levels of these cytokines was observed but a general pattern of significant 
suppression of their protein levels (except IL-la at medium dose) showed that 
both toxins regulate the cytokine expression differently. 
Based on the above discussed results and others, AFB1 may alter cell-
mediated immunity by affecting the communication between macrophages and 
T lymphocytes through inhibiting the macrophage-producing cytokines. T-2 
toxin-induced immunosuppression may be due not only to the inhibition of 
v 
macrophage-producing cytokines, but also to the lack of effector cells to respond 
to the cytokines (IL-2, IFNy, and IL-3). 
(153 pages) 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
Immunotoxicology is the discipline of toxicology devoted to the study of 
the immune system as a target for the toxicity of xenobiotics, drugs, and 
chenticals. This area is recently receiving a great deal of attention because a 
number of xenobiotics, drugs, and chemicals are proven to be 
immunomodulators. The immune system is very complex; it consists of a large 
number of different types of cells that are rapidly proliferating in a highly 
organized network. This network is very sensitive to several external factors. 
Any imbalance in the system may lead to immunosuppression, allergy, 
autoimmunity, or cancer. Cytokines or interleukins (ILs) are soluble factors 
produced by macrophages, T lymphocytes, and other cell types of the body 
when they are activated by specific antigens. They are the key signaling 
molecules between the immune cells and act in that microenvironment to help in 
the development of acquired immunity. Any modulation in the production of 
ILs will lead to either immunosuppression or immunostimulation. Results from 
the use of immunosuppressive drugs such as cyclosporin A and FK506, which 
are known to suppress the production of cytokines, suggest that mycotoxins, 
which are also immunomodulators, might cause immunotoxicity by interfering 
with the production of cytokines. 
CYTOKINES AND THEIR ROLE 
IN THE IMMUNE RESPONSE 
2 
Cytokines are soluble factors produced by macrophages, T lymphocytes, 
and other cell types of the body when they are activated by specific antigens. 
Macrophages produce cytokines such as IL-l (IL-Ia and !L-Ip), IL-6, and tumor 
necrosis factor (TNF) (Akira et al., 1990). There are two different subtypes ofT-
helper cells: THl cells that produce IL-2 and interferon y (IFNy) and TH2 cells that 
produce IL-4 and IL-10; IL-3 is produced by both cell types (Mosmann and 
Coffman, 1989). Cytokines play very important roles in promoting ceil growth, 
differentiation, and functional activation of immune cells. These growth and 
differentiation factors act on different cell types by autocrine or paracrine activity 
to help clear the antigens in different ways. Current research indicates that 
cytokines are not restricted to one specific function but are multifunctional 
molecules with a variety of activities, some of which are overlapping with those 
of other cytokines. This kind of pleiotropy and redundancy of cytokines is 
exerted not only on the immune cells but also on many target cells and tissues, 
including even the nervous system (reviewed by Mizel, 1989). 
Macrophages or monocytes are important in the regulation of humoral 
and cell-mediated immunity apart from their phagocytic and cytotoxic action 
against foreign invaders. When foreign antigens enter the body, they are taken 
and processed by macro phages and presented to T cells, thereby activating the T 
3 
cells. In this process, macrophages produce cytokines like IL-l (IL-la and -1~), 
IL-6, and TNF, and activated T lymphocytes (mainly T-helper cells) produce IL-2, 
IL-3, and IFN (reviewed by Mizel, 1989; Germain, 1994). These growth and 
differentiation factors act on different cell types by autocrine or paracrine 
pathways to make them more effective in clearing the antigens in different ways; 
these will be addressed briefly and individually. 
Inter/eukin-1. Interleukin-1 (mainly derived from macrophages) is the 
term for the two polypeptides (IL-la and IL-l~) that have a wide spectrum of 
inflammatory, metabolic, physiologic, hematopoietic, and immunologic 
properties. IL-l is initially synthesized as a 33-kDa precursor, and subsequently 
processed to 13-17 kDa (Mizel, 1989). IL-1 participates in the mechanisms ofT 
and B cell activation; its receptors are not expressed in the resting lymphocytes. 
The T cell activating property of IL-l is measured by it's ability to act in a co-
stimulator assay with sub-optimal concentrations of antigens or mitogens 
(Dinarello, 1992). IL-l amplifies T cell activation by inducing expression of IL-2 
and IL-2R genes, particularly in conjunction with mitogens, antigens, calcium 
ionophores, or stimulators of protein kinase C (Simic and Stosic, 1985). IL-l, 
along with IL-4, also acts as a helper or co-factor during the activation process of 
B cells and Ig production. It also affects hematopoiesis by inducing the 
production of GM-CSF, C-CSF, M-CSF, and IL-3; it acts synergistically with CSFs 
and other cytokines on hematopoiesis (Bagby, 1989). 
lnterleukin-6. 
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Interleukin-6 is a cytokine mainly produced by 
macrophages, with pleiotropic activities that play a central role in host defense. 
It is a glycoprotein with a molecular mass in the range of 20-30 kDa, depending 
on the cellular source and preparation (Akira et al., 1993). IL-6 acts mainly on the 
late phase of the B cell differentiation pathway, consistent with the finding that 
interleukin-6 receptor is expressed on activated B cells but not resting B cells 
(Taga et al., 1987). It acts on mitogen-activated B cells to induce IgM, IgG, and 
IgA production without stimulating B cell proliferation (Muraguchi et al ., 1988; 
Beagley et al., 1989). IL-6 synergizes with IL-l for T cell proliferation and 
cytotoxic T lymphocyte generation via induction of IL-2 (Houssiau and Van 
Snick, 1992). IL-6, along with IL-3, induces proliferation and differentiation of 
bone marrow progenitor stem cells (Suzuki et al., 1989); it also enhances 
phagocytosis and expression of a number of macrophage differentiation 
antigens, including Mac-1 and Mac-3, major histocompatibility complex class I, 
nonspecific esterases, lysozyme, 2',5'-A-synthetase, and C-frns, indicating the 
functional differentiation into mature macrophages (Akira et al., 1993). 
Tumor necrosis factor. Tumor necrosis factor is largely produced by 
macrophages, and plays an important role in the defense against viral, bacterial, 
parasitic, immune, and autoimmune diseases. Tumor necrosis factor is 
synthesized as a precursor protein of 26 kDa, which is processed to a secreted 17 
kDa (McGeeham et al., 1994). The pleiotropic effects of TNF include cytostatic 
5 
and cytotoxic activity on malignant cells and cells infected by viruses or bacteria. 
It is also involved in the induction of cytotoxic T lymphocytes, enhancement of 
the killing activity of macrophages and natural killer (NK) cells, and activates the 
immune system by the generation of cytokines (IL-2, IL-7, IL-12) (Fiers, 1991). 
Interleukin-2. Interleukin-2 plays a more pivotal role in initiating and 
potentiating the immune response than any other lymphokine secreted by T 
lymphocytes. It provides a critical signal necessary for both T cell proliferation 
and antibody secretion by B cells. As deduced from the eDNA sequence, the 
mature murine IL-2 contains 149 amino acids and molecular weights range from 
15.5 to 31 kDa (Kashima et al., 1985). The mechanism of IL-2 activation ofT cells 
is the best understood among all known cytokines (Taniguchi and Minami, 
1993). Interleukin-2 also helps in long-term growth and functional 
responsiveness of antigen-specific CTL clones (Gillis and Smith, 1977). It also 
induces the IL-2 receptor expression in T cells and acts on NK cells and 
monocytes (Smith and Cantrell, 1985; O'Garra et al., 1988). 
Interleukin-3. Interleukin-3 is a T lymphocyte-derived 28 kDa 
glycoprotein that contains 38% carbohydrate. The murine IL-3 gene encodes a 
protein of 166 amino acids. The first 26 amino acids encode a typical 
hydrophobic leader sequence required for secretion (Fung et al., 1984). 
Interleukin-3 activates macrophages in different ways. Morphological changes 
and increased phagocytosis in IL-3-activated peritoneal macrophages were 
6 
reported (Crapper et al., 1985). Interleukin-3 also induces Ia and the class II 
molecule LFA-1 expression in macrophages, thereby increasing the antigen 
presenting capacity to T-helper cells but not cytotoxicity (Frendl and Beller, 
1990). Production of IL-l, IL-6, and TNF in macrophages is dramatically 
increased by the exoposure of peritoneal macrophages to IL-3, showing that IL-3 
is one of the key elements in macrophage activation (Frendl, 1992). 
Interferon y. Interferon y is produced by T lymphocytes, including 
helper/ suppressor phenotypes (Kasahara et al., 1983). The protein contains 143 
amino acids with a molecular weight ranging from 20 to 25 kDa. Although lFNy 
is best known for inducing anti-viral activity, it can also modulate the function of 
a number of cell types important in the immune response (Friedman and Vogel, 
1983). IFNy plays a key role in the activation ofT cells by stimulating increased 
expression of the IL-2R, which allows the continued proliferation of T cells in 
response to IL-2. In turn, the T cell response to IL-2 enhances the production of 
IFNy (Farrar et al., 1986), thereby creating an interdependent network ofT cell 
responses, which allows the continued production of soluble factors. This 
network increases tumor killing activity, phagocytosis, and induction of class II 
major histocompatibility antigen complex (!a) in macrophages, and activation 
and growth enhancement of CTL-cells and NK-cells (Trincheiri and Perussia, 
1985). IFNy is also known to induce oxygen-dependent, or respiratory burst-
dependent microbicidal activity in the macrophage (Sasada and Johnson, 1980), 
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and oxygen-independent macrophage activity by enhancing indole amine 2, 3-
dioxygenase (100) activity (Pfefferkorn, 1984). 
The summary of the above discussed cytokine communication network 
during immune response is illustrated in Figure I-1 . 
REGULATION OF CYTOKINE GENE EXPRESSION 
From the above discussion, it is clear that cytokines are very crucial 
signals for the development of the immune response. A single cytokine shows 
pleiotropism by acting on different targets, and different cytokines demonstrate 
redundancy by acting on the same target, showing similar effects. This is the 
main reason cytokines are regulated tightly at the transcriptional and 
translational levels: otherwise, the overproduction or underproduction of any 
particular cytokine would be very harmful to the body. For example, 
overproduction of TNF and IL-1 causes severe pathological symptoms such as 
inflammatory autoimmune diseases, one example of which is rheumatoid 
arthritis (Brennan and Feldmenn, 1992). Immunosuppressive effects of drugs 
such as cyclosporin A are mainly due to their effect on the down-regulation of 
IL-2 and other cytokines (Hess et al., 1988). Regulation of cytokine expression 
may occur at the transcriptional, post-transcriptional, translational, or post-
translational levels. 
TNF ....... _--1 ... ~ 0 __. 
I / m•aoph•S' cytotoxicity phagocytosis 
anti-viral, ....__ 
tumor cytotoxicity 
I J IFNy 
e/ t 1"1 ~~;'- IL-l 
e~ ~ " NK-cell 
THl IFNy l ~-3 
T cell proliferation f.\ 
IL-2 receptor ~ V ~ IL-2 
expression 
an tigen presentation IL-3 
I IL-4 
' IL-10 
G B-cell 
' B-cell proliferation, antibody synthesis 
Fig. I-1. The cytokine communication network during immune response. 
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Cytokine genes, like many other eukaryotic genes, contain regulatory 
elements such as promoters, enhancers, and silencers. These elements are 
composed of discrete DNA sequences called cis-acting elements, which are 
binding sites for sequence-specific DNA binding proteins called trans-acting 
proteins. These cis-acting elements are generally directly upstream of the 
promoter and the two elements act in concert to achieve a fine degree of control 
over the transcriptional activity of the cytokine genes. Trans-acting factors such 
as NFAT (~uclear _Eactor of Activated I cells), AP-1, AP-3, NF-KB (~uclear 
_Eactor-!;appa !l_), NF-IL6 and OBP (OCT-1 !l_inding froteins) bind to the upstream 
regions of the promoters of cytokine genes and regulate the intiation of the 
transcription in a differential way (Riegel et al., 1992; Chen-kiang et al., 1993; Rao, 
1994). Many immunosuppressive drugs such as cyclosporin A and FK506 are 
known to repress the induction of the transcription factors, thereby preventing 
the transcription of the cytokines (Emmel et al., 1989; Brabletz et al., 1991). 
Post-translational mechanisms involving factors regulating the mRNA 
stability also play important roles in the gene regulation of cytokines. This is a 
very active area of research that remains unclear. Reiterated AUUUA pentamers 
(ARE) found within the 3'-untranslated regions (UTR) of IL-la, IL-1P, IL-2, IL-3, 
TNF, IFNy, G-CSF, and GM-CSF appear to function as cis-regulatory elements 
capable of regulating both the turnover and translation of these cytokines (Shaw 
and Karmen, 1986; Han et al., 1990; Henics et al., 1994;). This cis-regulatory 
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element appears to control the mRNA stability both positively and negatively by 
binding to different AU-rich sequence binding proteins (AUBP). In IL-2, AUBP 
bind directly to the AU-rich 3' -UTR and increase the stability of mRNA in tumor 
cells (Henics et al., 1994). However, Cockfield et al. (1993) argued in their 
discussion that cycloheximide-induced superinduction of IFNy and TNF is due to 
its inhibition of synthesis of labile RNase proteins responsible for the 
degradation of mRNA targeting the AU-rich region. Further studies are ongoing 
to characterize different types of AUBP and their role in the regulation of 
turnover and translation of cytokine mRNAs. 
Initiation of translation of regulatory proteins (growth factors, cytokines, 
etc.) is influenced by the different aspects of the mRNA structure: m7G cap, the 
primary sequence or context surrounding the AUG codon, leader length, and 
secondary structure both upstream and downstream of the AUG codon (Kozak, 
1991). AU-rich 3'-UTR region in TNF is necessary for its efficient translation in 
endotoxin-treated AU-rich 3'-UTR constructs containing cell lines (Han et al., 
1990); this shows that secondary structural features of mRNA at the 3' -UTRs are 
very important for the efficient translation of these cytokines. 
Production of interleukin-la and TNF is also regulated at the processing 
and secretion levels. IL-la and IL-l~ do not possess a typical NH2-terminal 
hydrophobic secretory signal sequence to translocate directly into the cytoplasm 
via the classical exocytic secretory pathway (Giri et al., 1985). As a consequence, 
11 
the newly .synthesized IL-Ia precursor proteins are localized in the cytoplasm: 
There they are cleaved by the proteolytic enzyme calpain and undergo a 
conformational change that exposes a required secretory signal causing their 
secretion upon activation by a subsequent activation signal (Carruth et al., 1991; 
Hazuda et al., 1991; Siders et al., 1993). Pentamidine, an aromatic diamine 
currently used to treat Pneumocystis carinii, specifically inhibits the cleavage of 
pro-IL-1a and inhibits its secretion (Rosenthal et al., 1991). A similar kind of 
inhibition of cleavage of pro-TNF into the secreted form is also observed with t.9-
tetrahydrocannabinol, a major psychoactive component of marijuana, in a mouse 
macrophage cell line (Fischer-Stenger et al., 1993). 
GENERAL TOXICOLOGY OF AFLATOXIN 
B, AND T-2 TOXIN 
Aflatoxins (AFs) are produced by several strains of aspergillus, especially 
A. jlavus and A. Parasiticus, that grow on food crops. The parent AFs, all of 
which occur naturally, are a group of structurally related compounds that 
possess a coumarin nucleus fused to a bisfuran moiety and either a pentanone, 
such as in AFB, and AFB2 , or a six-membered lactone, as in the case of AFG, and 
AFGz (Figure I-2). Aflatoxin M, and AFM, are hydroxylated forms of AFB1 and 
AFB,. Aflatoxin B,a and AFG,a are 8, 9-hydrated products of AFB, and AFG1 
(Coulombe, 1991; McLean and Dutton, 1995). Aflatoxin B1 is usually found in the 
highest concentrations, followed by AFG1, AFB,, and AFG,. The order of acute 
0 0 
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~ 
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and chronic toxicity is AFB1>AFG1>AFB2>AFG, (Wogan, 1966), reflecting the role 
played by epoxidation of the 8, 9-double bond and the greater potency associated 
with the cyclopentinone ring of the B series, when compared with the 6-
membered lactone ring of the G series. 
Aflatoxicosis caused by AFB1 and related toxins represents one of the most 
serious diseases of man, as well as poultry, livestock, and other lower animals 
such as rat and mouse. Acute aflatoxicosis in poultry causes hemorrhages in 
many tissues, decreases egg production, and causes anorexia, stunting, and 
hepato toxicosis with icterus. Microscopically, evidence of hepatotoxicosis has 
included parenchymal degeneration with vacuolation, biliary hyperplasia, and 
necrosis followed by cirrhosis. Low concentrations have been reported to cause 
weakness and decreased resistance to disease, and have induced carcinogenesis 
in many species (Newberne and Butler, 1969; Edds, 1973; Mollenhauer et al., 
1989). One important property of AFB1 is its mutagenicity and carcinogenicity. 
Aflatoxin B1 causes hepatoma and other tumors in a variety of animal species 
(Robens and Richard, 1992). A number of epidemiological investigations have 
also implicated its role in the etiology of human liver cancer (Van Rensberg et al., 
1985; Yeh et al., 1990). The chemical activity of AFB1 is thought to proceed via the 
formation of the 8, 9,-epoxide that can react with DNA and RNA to form a 
covalent adduct at the N7 position of guanine residues (Croy et al. , 1978). The 
dihydrodiol form of AFB,, which is the hydration product of AFB1-8, 9, epoxide, 
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forms a schiffs base with amino groups of the bases (Hsieh, 1987). These 
interactions of AFB, with macromolecules will definitely affect their biosynthesis 
and increase possible mutations, which may induce cancer. Aflatoxin B, has been 
demonstrated to activate the Ki-ras gene in rat liver. In this regard, in the final 
stages of AFB,-induced rat liver hepatocellular carcinoma (HCC), two activating 
mutations in the codon 12 region of Ki-ras genes [GGT to GAT (McMahon et nl., 
1987) and GGT to TGT (Sinha et al., 1988)] have been identified. Soman and 
Wogan (1993) have confirmed the Ki-ras codon 12 GGT to GAT mutation in rat 
liver, suggesting the involvement of this genetic mutation in the development of 
AFB1-induced HCC in rats. Mutation in the third base of the codon 249 (G toT) 
in p53 tumor suppression gene has been shown in Chinese patients exposed to 
aflatoxin (Hsu et al., 1991). However, there is a controversy involving these facts: 
Because these mutations do not correlate with the human HCC, there may be 
some other etiologic factors such as HBV infection also involved in the 
development of these liver cancers (Nose et al., 1993). 
Macromolecular syntheses such as DNA, RNA, and protein are also 
shown to be affected by AFB1. Covalent binding of AFB, to DNA leads to the 
modification of DNA template activity and/or inactivation of certain enzymes in 
DNA synthesis (Hsieh, 1987). RNA polymerase II activity and synthesis of rat 
liver RNA, especially nucleolar RNA synthesis, are inhibited by AFB, (Yu, 1977). 
RNA chain elongation and post-transcriptional processing of nuclear RNA are 
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also shown to be inhibited by the AFB, (Yu, 1981; Harley eta/., 1969). Inhibition 
of protein synthesis by AFB, may arise directly from inactivation of biosynthetic 
enzymes, or inhibition of translation, and/ or interference with arninoacid 
transport (Hsieh, 1987). Disrupted membranes of endoplasmic reticulum due to 
the direct damage by AFB, may interfere with ribosome binding, and protein 
synthesis may be stopped (Terao and Ueno, 1978). 
T-2 toxin is a secondary metabolite produced by Fusarium tricinctum, 
which grows on such crops as corn (Sharma and Salunkhe, 1991). It belongs to 
the family of mycotoxins called trichothecenes, and contains a common 
trichothecene skeleton with cyclopentane, cyclohexane, and a 6-membered 
oxyrane ring with four methyl groups. The skeleton contains an epoxide ring at 
C-12, 13 and a double bond at C-9, 10, characterized as 12, 13-epoxytrichothec-9-
ene and are important for the trichothecene toxicity (Sharma and Kim, 1991). 
The numbering system is shown in Figure 1-3. The trichothecenes are divided 
into simple and macrocyclic trichothecenes, depending on the presence of a 
macrocyclic ring linking at C-4 and C-5 with diesters or triesters. Simple 
trichothecenes are again divided into three types, namely type A, B, and C. Type 
A trichothecenes include T-2 toxin, neosolaniol, HT-2 toxin, and others. Type B 
trichothecenes, characterized by the presence of a ketone group in the C-8 
16 
16 
15 
14 
Fig. I-3. The numbering system of trichothecene. 
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position, include nivalenol, fusarium-X, and deoxynivalinol (Table 1-1) (Sharma 
and Kim, 1991). 
One of the best known human diseases associated with the trichothecenes 
in humans is alimentary toxic aleukia (Joffe, 1978). This disease may be divided 
into four stages clinically. Shortly after ingestion of contaminated food, 
symptoms such as burning sensation of mouth, tongue, throat, palate, 
esophagus, and stomach are evident due to the toxin's inflammatory action on 
the mucus membrane. Progressive leukopenia and granulopenia in the second 
stage will render the body susceptible to infections. Continuous intake of the 
toxin will cause petechial hemorrhages on the skin in the third stage followed by 
necrosis in tonsils and throat, causing angina in the final stage. Recently another 
human toxicosis in China was reported due to the ingestion of moldy rice 
contaminated with T-2 toxin (Wang et al., 1993b). The main symptoms are 
nausea, dizziness, vomiting, chills, abdominal distention and pain, thoracic 
stuffiness, and diarrhea. 
Gross and pathological changes are also observed in various large and 
laboratory animals treated with T-2 toxin. Swines treated with 0.6 to 5.4 mg 
(single dose) per kilogram body weight showed gross and microscopic changes 
(Pang et al., 1987). Gross lesions include edema, congestion, hemorrhage of the 
lymph nodes, pancreas, gastrointestinal mucosa, subendocardium, etc. 
Microscopic lesions include degeneration and necrosis of lymphoid tissues and 
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TABLE 1-1 
Structures of selected trichothecenes 
nO~tR, 
HR; : elf~ H A, TYPE A 
n, n, 
Name R, R, Rl R, Rs 
T-2ioxin OH OAc OAc I! OCOCH2CH(CH1h HT-2ioxin OH OH OAc H 0COCH,CJI(CH1), Ncosolariiol OH OAc OAc H OH Diacc1ox ysci pcnol Off OAc OAc H H T-2 tclrnol OH Off OH H Off Acc1yl T-2toxin OAc OAc OAc H OCOCH,CJI(CH1), );tjH· TYPE8 
····, n, 
H 
•A, 
Nivalenol OH OH OH OH l'usarenon·X OH OAc OH OH Diacerylnivalenol OH OAc OAc OH Deoxynivalcno! OH H OH OH 
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epithelium of gastrointestinal mucosa, mild scattered necrosis of pancreatic cells, 
myocardium, bone marrow cells, adrenal cortical cells, and tubular epithelium of 
renal medulla. These findings suggested that T-2 toxin damages both rapidly 
dividing and nondividing cells. Oral exposure of male CD-1 mice with T-2 toxin 
(2.5 mg/kg) for 2-4 weeks also led to ulcerations, lymphocyte infiltration, 
epithelial proliferation, and hyperkeratinization of the forestomach (Taylor eta/., 
1989). 
T-2 toxin is cytotoxic to many cell types, causing damage to the tissues. 
Mice treated with T-2 toxin (0.30 mg/kg) had decreased bone marrow cellularity, 
suggesting that extremely small doses of T-2 toxin can produce a significant 
degree of bone marrow cytotoxicity (Faifer eta/., 1992). Hypocellularity of CD4+ 
and CDS+ T cells in thymus and T cells in spleen are observed in T-2-toxin-
treated mice (Smith et a/., 1994), suggesting that T-2 toxin can be cytotoxic to 
specific subsets of cell types. 
The mechanism of the toxicity of T-2 toxin is still not clear. T-2 toxin is a 
potent inhibitor of protein synthesis (McLaughlin, 1977): It selectively inhibits 
peptide bond formation in the late stage of translation initiation and early 
elongation (Cundliffe et al., 1974; Smith eta/., 1975). The correlation observed 
among T-2 toxin binding to the 605 ribosome, cellular accumulation of the toxin, 
and the inhibition of protein synthesis (Middlebrook and Leatherman, 1989a, b) 
suggests that cytotoxic action of T-2 toxin may be due to the inhibition of protein 
20 
synthesis. DNA and protein synthesis are suppressed in bone marrow, spleen, 
and thymus in mice treated with T-2 toxin (0.75 mg/ kg i.p.) for 8 and 20 hr 
(Rosenstein and Lafarge-Frayssinet, 1983), which shows that DNA synthesis 
inhibition is also a factor in the toxicity of T-2 toxin. 
IMMUNOTOXICOLOGY OF AFLATOXIN B1 
AND T-2 TOXIN 
Immunosuppressive effects of these mycotoxins have been explored in 
many animal species (reviewed by Sharma, 1993). Low-level aflatoxin intake has 
the potential to cause serious economic losses to the livestock producer through 
reduced productivity or through the impairment of resistance to infectious 
agents. Continuous treatment with AFB1 in the diet (0.5 ppm) for 3 weeks 
reduced the acquired resistance to Pasturella multicida strain X-73 in turkey poults 
when these animals were immunized against the organism (Pier and Heddleston, 
1970). Partially purified aflatoxin-fed pigs (760 mg) for 4 weeks increased the 
severity of En;sipelothrix rhusiopathiae infection (Cysewski et al., 1978). 
Impairment of phagocytosis was observed in vitro in heterophils when 
chickens were fed 0.625-10 ppm aflatoxin and presumed to be due to the 
inhibition of production of protein factors by the heterophils (Chang and 
Hamilton, 1979). Cell adherence and phagocytic potential of turkey peritoneal 
macrophages are decreased when AFB1 (0.01, 0.1, 0.5, 1, and 5 mg) was added in 
vitro in the presence of a chicken microsomal mixed function oxidase system. 
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These results show that metabolized active forms of AFB1 are responsible for the 
action (Neldon-Ortiz and Qureshi, 1991). Along with the peritoneal 
macrophages, macrophages resident in lungs and in the liver are also affected by 
AFB1. Alveolar and peritoneal macrophages from rats and mice treated with 
AFB1 either by aerosol inhalation (3.17 mg/kg) for 60 min or intratracheal 
instillation (50-150 mg) showed suppression of phagocytosis (Jakab et al., 1994). 
Aflatoxin B1, AFQ1, and M1 (0.1-1 pg/ ml) pretreated rat kupffer cells for 2-24 hr 
in vi tro showed inhibition of phagocytosis, intracellular killing of Candida 
albicans, and anti-Herpes virus activity. But the AFB, is the more potent among 
the metabolites tested, suggesting that AFB, inhibits macrophage functions 
(Cusumano el al., 1995). 
Male CD-1 mice receiving 0.03-0.7 mg/ kg AFB, orally every other day for 
2 weeks showed decrease in T lymphocyte response (Reddy et al., 1987). A 
decrease in [3H] thymidine uptake was seen when splenic cells were cultured 
with lipopolysaccharide (LPS), phytohemagglutinin (PHA), or poke weed 
mitogen (PWM). A decrease in T-dependent antibody production, no effect on 
T-independent antibody production, and a dose-related suppression of delayed-
type hypersensitivity reaction to keyhole limpet hemocyanin were also observed 
in the above studies. In a similar study (Reddy and Sharma, 1989), where 
BALB/ c mice are treated with similar concentration AFB, for 4 weeks, 
suppression ofT-helper cells and T-suppressor cells, and NK-cell activity have 
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been observed. These studies clearly suggest that AFB1 affects cell-mediated 
immunity even in very low doses. 
Aflatoxin B1 is considered a potent mutagen and carcinogen even in the 
immune cells; many studies have shown chromosomal aberrations due to AFB1 
exposure of immune cells. Significant aberrations in male Chinese hamster bone 
marrow cells are observed within 5 days of administration of AFB1 (0.1-5 mg/ kg) 
(Barta et al., 1990). Graded doses of AFB, (1.09-17.4 mg/g embryo), applied on 
18-day chick embryo, induced sister chromatid exchanges in the replicating DNA 
ofT and B lymphocytes (Potchinsky and Bloom, 1993). 
Aflatoxin B, is also known to affect the granulocyte-macrophage 
progenitor cell differentiation into formation of granulocyte and macrophage 
colonies in vitro. Bone marrow progenitor cells from AFB, (0.03-07 mg/kg)-
treated mice showed a significant decreased capability to differentiate when 
cultured in vitro with the LPS-activated mouse serum (Dugyala et al., 1994). 
Similar effects of inhibition of granulopoiesis by AFB, are also shown in rats 
(Cukrova et al., 1992a), showing that AFB, may modulate immune functions by 
inhibiting the differentiation of progenitor cells into mature progenies. 
Very few studies have looked into the alteration of cytokines by AFB1 . 
Hatori et al. (1991) observed that C57Blj6 mice treated with 0.03-0.75 mg/kg 
AFB1 for 4 weeks showed a decrease in the production of IL-2 by splenocytes 
when activated with Con A in vitro. Increased production of IL-1 and IL-2 in 
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peritoneal macrophages and splenocytes, respectively, when activated with 
mitogens in v itro, is observed in rats treated with AFB1 (i.p. 1 mg/kg, single dose) 
(Cukrova et al., 1992b). Tumor necrosis factor production in alveolar 
macrophages is decreased in rats treated with AFB1 (50-150 mg) intratracheal 
instillation for 3 days (Jakab et al., 1994). In another in vitro study with the bovine 
monocytes, AFB1 (10 mg/ml) pretreatment for 24 hr inhibited the IL-Ia mRNA 
levels and IL-1 secretion. The authors suggested that the inhibition is general 
since the concentration of AFB1 used in this study also inhibited the 
constitutively expressed ~-actin (Kurtz and Czuprynski, 1992). These results 
confirm that the cytokine modulatory role of AFB1 and discrepancies found in 
the results in various studies may be due to the utilization of different 
experimental designs. 
Immunosuppression is the common toxicological manifestation in 
humans as well as in various laboratory and food animal species following T-2 
toxin exposure. Numerous studies have shown that the thymus is one of the 
main target organs of T-2 toxin. Other major organs of toxicity are bone marrow 
and spleen. Mice fed with T-2 toxin (20 ppm for 7-41 days) showed atrophy in 
thymus, Peyer's patches, and white pulp of spleen and bone marrow cells. 
Microscopically, decreased lymphocytes from thymic cortex, hypocellularity in 
bone marrow, and splenomegaly show that T-2 toxin is cytotoxic to the immune 
cells (Hayes et al., 1980). Similar results were also observed in thymus and 
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spleens of CD-1 mice when treated with T-2 toxin (2.5 mg/ kg for 2-4 weeks) 
(Taylor et al., 19S9). However, recent studies with the specific antibodies to the 
surface antigens of the different subsets of the lymphocytes showed that T-2 
toxin does not show a general cytotoxicity in thymus and spleen but alters 
specific subtypes of T and B cells. T-2 toxin (1.75 mg/kg) exposure in mice 
showed an increase in CDS- CD4- (immature thymocytes) cells and a decrease in 
CDS+ CD4+ cells (Smith et al., 1994), suggesting that T-2 toxin may affect thymic 
maturation. Mature T cells were also decreased in spleens in the same study, 
suggesting that cell-mediated immune functions are affected. T-2 toxin exposure 
(1.2 or 1.5 mg/kg) in mice selectively decreased the prolymphoid cell population 
in the fetal liver (Holladay el al ., 1993; Holladay et al., 1995). These studies 
provide support to the premise that lymphoid progenitor cells represent highly 
sensitive targets of T-2 toxin exposure. 
Alteration of cell-mediated immune functions is also observed in T-2 
toxin-exposed animals. Male CD-1 mice exposed to T-2 toxin (0.02-5.0 mg/kg) 
for 2-4 weeks showed suppression of PHA (T cell mitogen)-stimulation of splenic 
lymphocytes. Delayed type hypersensitivity is decreased even in the lower 
doses, suggesting that cell-mediated functions regulated by T cells are largely 
affected (Taylor et al., 19S5). Swiss mice treatment with T-2 toxin (i.p. with 0.75 
mg/kg, 24 hr for 7 days) was also shown to prolong the period required for 
allograft rejection and decrease the T-dependent antibody production 
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(Rosenstein et al., 1979). However, results from the data of various investigators 
should be analyzed cautiously before a conclusion can be reached due to their 
use of different experimental designs and treatment schedules. For example, 
mice receiving (i.p.) 1/2 LD 50 on day 0 and 1/4 LD 50 of crude T-2 toxin on day 
1 showed a decrease in the PHA and LPS stimulation of splenocytes; and mice 
receiving (i. p.) 1/12 LD 50 of crude T-2 toxin for 15 days showed an increase in 
the PHA and LPS stimulation of splenocytes (Lafarge-Frayssinet et al., 1979). 
These results show that T-2 toxin stimulates the lymphocyte functions in the low 
doses and suppresses them in the high doses of treatment. 
Similar kinds of discrepancies were also observed in studies involving 
cell-mediated inununity to Listeria monocytogeneses and T-2 toxin exposure. 
Preinoculation treatment with a single dose of T-2 toxin (p.o. 4 mg/kg) on day 2 
or 4 prior to Listeria challenge significantly enhanced resistance and decreased 
mortality due to listeriosis by as much as 50%. In contrast, resistance was 
suppressed and mortality was increased by 50% in mice that were treated with 
toxin after the Listeria challenge (Carrier et al., 1987). 
T-2 toxin and other trichothecene effects on the macrophages were 
studied: T-2 toxin is cytotoxic to rat alveolar macrophages (AM) in vitro 
(Gerberick and Sorenson, 1983). Scanning electron microscope examination of 
AM treated with 0.1 mM T-2 toxin demonstrated detachment of pseudopodia, 
cellular blebbing, smoothing of membrane processes, and finally cell lysis. T-2 
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toxin also .inhibited chemotaxis, chemiluminescence stimulated by bacteria, and 
phagocytosis of bacteria in rat leukocytes (Yarom et al., 1984). T-2 toxin 
decreased both MHC class II (Ia) expression and antigen presentation by 
epidermal Langerhans cells in mice (Blaylock et al., 1993). In another interesting 
study, enriched T lymphocytes from Fusarenon-X (a trichothecene)-treated 
mouse spleens showed no functional abnormality as they helped in vitro 
production of antibodies by PWM. However, there was a marked inhibition of 
antibody formation when the macrophages were added to the T lymphocytes, 
clearly showing that T-helper functions are inhibited by the Fusarenon-X-treated 
mice macrophages (Masuda et al., 1982). The above discussed studies show that 
T-2 toxin and other trichothecenes affect cell-mediated immunity via inhibiting 
macrophage structure and functions. 
Few studies have been conducted on the alteration of cytokines by T-2 
toxin and other closely related trichothecenes. Spleen cells from mice treated for 
4 consecutive days with 2 mg/kg T-2 toxin exhibited 4-fold higher levels of IL-2 
than control mice but a 50% reduction in in vitro Con A activation (Holt et al., 
1988). A plausible explanation for the reduction of activity may be the lack of 
enough effector cells to respond to IL-2. Increased levels of IL-2, IL-4, and IL-5 
are also observed in EL-4.IL-2 thymoma cells activated in vitro with 
Deoxynivalenol (trichothecene) (Dong et al., 1994). 
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Stress response due to the T-2 toxin exposure may also play a role in T-2 
immunomodulation. Endotoxemia is caused by the increased levels of endotoxin 
in the circulation, which is the result of T-2 toxin exposure in mice (Taylor et al., 
1989). A parallel increase of corticosterone due to the stimulation of 
hypothalamic-pituitary-adrenal axis, and the incidence of endotoxemia 24 hr 
after exposure to T-2, suggested that the stress response are due to systemic 
endotoxemia (Taylor et al., 1989). In another study, brain biogenic monoamines, 
i.e., norephinephrine, serotonin, and 5-hydroxy-3-indoleacetic acid, were 
increased in T-2 toxin-exposed rats (Wang et al., 1993a). The neuroendocrine 
system is known to affect the immune system (Fuchs and Sanders, 1994). 
Immunomodulatory effects of T-2 toxin may also be due to its indirect effects on 
the neuroendocrine system. 
In summary, both toxins are found to be immunotoxic in various species 
by influencing both cell- and humoral-mediated functions affecting mainly T-
helper cells and delayed type hypersensitivity functions. Macrophage functions 
like adherence, phagocytosis, and chemotaxis are also affected by both toxins. 
Many studies have shown the effects of xenobiotics on the immune system, but 
the mechanism of immunomodulation is still obscure. The main goal of this 
study is to investigate some of the molecular events that are involved in AFB1 
and T-2 toxin-induced immunotoxicity in male CD-1 mice. The working 
hypothesis is that these toxins may produce their immunotoxic effects via 
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interference with the synthesis of different cytokines in T lymphocytes and 
macrophages, thereby affecting the functions ofT lymphocytes and macro phages 
and their interaction with other immune cells. Moreover, there is no single study 
demonstrating the inhibition of cytokines at transcriptional or translational levels 
by these toxins. Functions of macrophages are evaluated by their ability to 
produce IL-1a, IL-6, and TNF and evaluation of T cell functions by measuring 
their ability to produce IL-2, IL-3, and IFNy. Both objectives are approached by 
quantifying the specific mRNA for each cytokine, employing Northern blot/ RT-
PCR techniques, and measuring the individual cytokine protein levels by 
sandwich ELISA, after in vitro induction with mitogens in control and toxin-
treated animals. 
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CHAPTER II 
ALTERATION OF KEY CYTOKINES PRODUCED BY MITOGEN-
ACTIVATED PERITONEAL MACROPHAGES AND 
SPLENOCYTES IN AFLATOXIN B1-TREATED 
MALE CD-1 MICE 
ABSTRACT 
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Male CD-1 mice were used to test the in vivo effects of aflatoxin B1 (AFB1) 
on the genetic expression of key cytokines that modulate activation and 
proliferation of splenic lymphocytes (IL-2, IFNy, and IL-3) and macrophages (IL-
1a, IL-6, and TNF) activated in vitro with LPS and Con A, respectively. Animals 
were treated with 0, 0.03, 0.145, or 0.7 mg AFB1/kg body weight orally every 
other day for 2 weeks. No significant effects of the toxin on the weights of liver, 
kidney, spleen, or thymus, or in red blood cell counts were noted, but white 
blood cell counts were significantly elevated at the low (0.03 mg/kg) dose. 
Cytokine mRNA levels were measured by RT-PCR or Northern blots and the 
secreted protein levels by ELISA. The low dose generally decreased both mRNA 
and protein levels of lymphocytic IL-2, IFNy, and IL-3, with IL-2 mRNA 
decreasing significantly from control levels (p~O.OS). No significant differences 
in mRNA or protein levels between treated and untreated controls were found at 
the medium or high doses for the three cytokines. AFB1 had a more marked 
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effect on macrophage-produced cytokines. While the mRNA levels increased 
significantly at the low (IL-la) or medium dose (IL-6 and TNF), their 
corresponding protein levels were generally suppressed. The levels of IL-la 
secreted protein were significantly suppressed at all dosages, and those of IL-6 
and TNF at high dose. Thus AFB1 treatment appears to preferentially affect 
macrophage functions. These observations and how they relate to possible 
mechanisms of AFB1 immunosuppression are discussed. 
INTRODUCTION 
Aflatoxins are a group of mycotoxins produced by different strains of 
fungi such as Aspergillus jlavus and parasiticus. Aflatoxin B1 (AFB1) represents by 
far the most toxic of the aflatoxins (Coulombe, 1993). It is a potent carcinogen 
that causes hepatoma and other tumors in a variety of animal species (Robens 
and Richards, 1992). Hepatic and renal lesions in male broiler chickens, and 
hepatic lesions in turkey, ducklings, cattle, pig, sheep, rat, guinea-pig, mouse, 
dog, cat, rabbit, monkey, and humans show that AFB1 affects almost all animal 
species (Mollenhauer et al., 1989; Newborn and Buttler, 1969). 
Immunotoxic potential of AFB1 is known in many species, including 
laboratory and domestic animals (Sharma, 1993). Decreased lymphocyte 
response to different mitogens was observed in several studies. Aflatoxin B1 is 
inhibitory to the phytohemeagglutinin (PHA)-stimulated lymphocytes in vitro in 
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cattle and humans (Bodine et al., 1984; Savel et al., 1970). Male CD-1 mice 
receiving 0.03-0.7 mg AFB1/kg body weight orally every other day for 2 weeks 
showed a decreased T lymphocyte response to lipopolysaccharide (LPS), PHA, 
and poke weed mitogen (PWM), and T-dependent antibody production in vitro 
(Reddy et al., 1987). Similar treatments in BALB/c mice for 4 weeks resulted in 
suppression ofT-helper/ suppressor cells along with the suppression of delayed 
type hypersensitivity and NK cell activity (Reddy and Sharma, 1989). These 
results strongly suggest that AFB1 affects cell-mediated immunity. 
Apart from the T lymphocytes, macrophages, which are also considered to 
be crucial in the immune response, are affected by the AFB1 . Macrophages are 
involved in the first line of defense aga inst infectious agents (Skamene and Gros, 
1983); they process and present the antigen to the lymphocyte (Unanue, 1984) 
and secrete the cytokines that activate and stimulate proliferation of lymphocytes 
and other effector cells during the immune response (Akira et al., 1990). Reduced 
phagocytosis and bactericidal abilities of heterophils from chicken were observed 
when fed with dietary aflatoxin (Chang and Hamilton, 1979). Inhibition of 
phagocytosis, intracellular killing of Candida albicans, and intrinsic anti-Herpes 
virus activity were observed in rat Kupffer cells when aflatoxins were added in 
v itro (Cusumano et al., 1995). Aerosol and intratrachial instillation of AFB1 
inhibits phagocytosis in alveolar and peritoneal macrophages in rats and mice 
(Jakab et al., 1994). 
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Although there is a large body of data demonstrating that AFB1 affects 
immunity, little is known about the mechanisms of its imrnunotoxicology 
(Sharma, 1993). Suppression may occur when a toxin affects the phagocytic 
and/ or antigen-processing capacity of the macro phages, the antigen recognition 
ability of the lymphocytes, the differentiation and proliferation of T and B 
lymphocytes, or the activation of immune effector mechanisms, including the 
production and release of cytotoxic lymphocytes, antibodies, and/ or delayed 
hypersensitivity mediators. Since cytokines affect all the above-mentioned 
processes directly or indirectly, it is only logical that AFB1 may produce its 
immunomodulatory effects through interference with the production of 
cytokines in macrophagcs and T lymphocytes. 
Few studies have been done involving cytokine production and AFB1 
exposure. Hatori et al. (1991) observed a decrease in concanavalin A (Con A)-
induced IL-2 production in mice treated with AFB1. Respiratory aflatoxicosis 
inhibits LPS-induced TNFa production in alveolar macrophages in rats (Jakab et 
al., 1994). Interleukin-1 production was decreased in LPS/Listeria monocytogenes-
induced bovine monocytes when pretreated with AFB1 in vitro (Kurtz and 
Czuprynski, 1992). These studies, however, did not explain whether the 
analyzed cytokines are inhibited at the transcriptional or translational level by 
AFB1. In the present study, mRNA and protein levels for key cytokines were 
determined in peritoneal macrophages (IL-1a, IL-6, and TNF) and splenic 
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lymphocytes (IL-2, IFNy, and IL-3) after exposure of CD-1 mice to various doses 
of AFB1 in vivo. The cytokines were selected on the basis of their known 
importance in the regulation of acquired immunity (Paul and Sedar, 1994; Akira 
et nl., 1990). 
MATERIALS AND METHODS 
Animals. Male CD-1 mice, 5 weeks old, were obtained from Charles River 
Laboratories (Wilmington, MA). Mice were acclimatized for 7 days in a 
temperature-controlled (22 ± 1 °C, 50% relative humidity) and artificially 
illuminated room (12 hr light cycle) of an AAALAC-accredited animal care 
facility. Pelleted feed (toxin free) and fresh water were provided ad libitum. 
Aflatoxin B1 exposure. Aflatoxin B1 was obtained from Sigma Chemical 
Co. (St. Louis, MO) and dissolved in a corn oil:ethanol (95:5) vehicle just before 
administration. Two sets of mice were separated into four groups (control, low, 
medium, and high dose) and were dosed with 0 , 0.03, 0.145, and 0.7 mg 
AFB1/kg body weight, respectively. The toxin was administered by oral gavage 
every other day for 2 weeks (seven doses). Body weights were recorded daily 
throughout the experimental period. Mice were euthanized by carbon dioxide 
48 hr after they were given the final dose. From one set of animals, the livers, 
thymus, kidneys, and spleens were removed and weighed and the blood was 
collected in heparinized tubes for red and white blood cell counts. The spleens 
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were removed asceptically and used to isolate splenocytes. The second set of 
animals was used for isolation of macro phages by intraperitoneal lavage. 
Isolation and activation of splenic lymphocytes. The asceptically 
collected spleens were maintained in cold complete RPM! [RPMI-1640 (Gibco, 
Grand Island, NY), 2 mM glutamine, 100 units/ml penicillin, 100 mg/ml 
streptomycin, 50 mM 2-mercaptoethanol, 10% heat inactivated fetal calf serum 
(FCS) (Hyclone Lab., Logan, UT)]. Monocellular cell suspensions were prepared 
using a Stomacher lab blender (STOM 80, Tekmar Co., Cincinnati, OH). Red 
blood cells were removed with ACK lysing buffer (0.15M NH4Cl, 1 mM KHC03, 
0.1 mM Na2EDTA, pH 7.4). The remaining cells were plated in Falcon 100-mm 
plates and incubated at 37°C for 1 hr to allow adherence of macrophages. The 
nonadherent cells were collected, counted by automatic blood cell counter 
(Coulter Electronic Inc., Hialeah, FL), adjusted to a concentration of 2x106jmJ, 
activated with 5 f.lg/ml Concanavalin A (Con A) (Sigma) in complete RPM!, and 
replated 15- 20 ml/ plate in 100-mm Falcon culture dishes for 12 or 48 hr. 
Isolation and activation of macrophages. Animals to be used for 
isolation of macrophages were injected intraperitoneally with 3 ml 3% Brewers 
thioghycolate broth (BIG) (Gibco). On the fourth day post injection, peritoneal 
lavage was performed with 5 ml ice-cold complete RPM! + 10 U/ml heparin. 
Macrophages were counted in a hemacytometer, adjusted to 106 cells/ml in 
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complete RPM! medium, and 5-ml cell suspension were plated in 60-mm dishes. 
To activate the cells, lipopolysaccharide (LPS) (Sigma) was added to each plate at 
a concentration of 10 f!g/ ml and cultured for 6 or 24 hr. 
Total RNA isolation and analysis. Total RNA was extracted from 
lymphocytes after 12 hr activation with Con A and from macrophages after 6 hr 
activation with LPS. The lymphocytes were harvested by centrifugation and 
total RNA was extracted from the pellet with TRI REAGENT™ LS (Molecular 
Research Ctr., Cincinnati, OH) per manufacturer's protocol. RNA from 
macrophages was extracted by removing the medium and applying TRI reagent 
to the adherent cells on the plate following manufacturer's instructions. The 
purified RNAs were suspended in FORMAzol (Molecular Research) and stored 
at-20°C. 
Northern analysis of IL-1a, IL-6, and TNF and control P-actin was done 
using antisense riboprobes labeled wi th a-32r-UTP or a32P-CTP to a specific 
activity -3 x 108 cpm. Antisense transcripts were generated using cloned cDNAs 
and the bacteriophage T3 or T7 RNA polymerase (Promega, Madison, WI), per 
manufacturer's instructions. Template cDNAs were as follows: for IL-1a, ATCC 
clone #63106 in pBluescript SK+, cut with Hind Ill and transcribed with T3; for 
IL-6, 800 bp eDNA clone (Pst lends) in pBluescript II KS+, cut with Hind Ill and 
transcribed with T7; for TNF, 1230 bp eDNA clone (Eco Rl ends), in pBluescript 
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ILKS+, cut wi th Hind III and transcribed with T7. The latter two clones were 
obtained from Dr. A. D. Weinberg (University of California, San Diego, CA). 
Human P-actin used as control was from ATCC, clone #78554 cut with Hind III, 
transcribed with T3. All the clones were sequenced from both ends and found to 
conform to respective eDNA sequences in Genbank. 
Ten micrograms of total RNA were fractionated through a 1.2% agarose 
gel containing 1.1% formaldehyde. The RNAs were transferred to MAGNA NT 
nylon membranes (Micron Separations Inc. Westboro, MA) . The membranes 
were stained with 0.02% methylene blue and photographed, and the positions of 
18S and 28S ribosomal RNA bands and RNA ladder size markers were noted on 
the membrane and later used for sizing and estimation of total RNA loaded per 
lane. Prehybridization (approx. 1 hr) and hybridization at 57°C (16 to 24 hr) 
were carried out in buffers containing 50% formamide and the membranes were 
washed under high stringency conditions per manufacturer's protocols. The 
blots were exposed from 6 hr to overnight to Kodak X-AR film at -70°C with 
Dupont Lightning Plus screens. The bands were quantitated by scanning their 
densities using ZERO-D scan software program (Stratagene Cloning Systems, 
LaJolla, CA). Total RNAs per lane were adjusted using p-actin standards and 
the percentage of cytokine RNA in mycotoxin-treated mice were calculated using 
untreated group values as 1. 
53 
IL-2, IL-3, and lFNy and P-actin were analyzed by reverse transcriptase-
polymerase chain reaction (RT-PCR) using Oligo 4.0-software-selected primer 
sets for each sequence as follows: 
IL-2 (611 bp): Sense= 5'-GCGCACCCACTTCAAGCTCC-3' 
Antisense= 5'-AGCCCTTGGGGCTT ACAAAA-3' 
IL-3 (567 bp): Sense= 5'-CCCTTGGAGGACCCAGAAC-3'; 
Antisense= 5'-GCCA TGAGGAACA TTCAGAC-3'. 
IFNy (510 bp): Sense= 5'-GTTCTGGGCTTCTCCTCCTG-3'; 
Antisense= 5'-CGAA TCAGCAGCGACTCCTT-3'. 
P-actin (265 bp): Sense= AACACAGTGTTGTCTGGTGG-3'; 
Antisense= 5'-ACGCAGCTCAGT AACAGTCC-3' 
First-strand synthesis was carried out using 1 ~g of lymphocyte total RNA 
and 0.5 ~g oligo (dTh2-18 (GibcoBRL), mixed in a 20-~1 total volume reaction 
containing 50 mM tris-HCl (pH8.3@RT), 75 mM KC!, 3 mM MgCl2, 10 mM OTT, 
0.5 mM each dATP, dCTP, dGTP, and dTTP (Promega), and 200 U SuperScript II 
RNase H- RT (GibcoBRL) in a 50-min incubation at 42°C. After heating at 70°C 
for 15 min, the mixture was chilled in ice, and 2 units of RNaseH (Boehringer 
Mannheim, Indianapolis, IN) were added, followed by a 20-min incubation at 37° 
C. Twenty microliters of sterile double-distilled water was then added to the 
eDNA and 2 ~1 of the diluted samples were used for each polymerase chain 
54 
reaction (PCR). The optimal MgC12 and primer concentration in a PCR reaction 
were determined empirically for each cytokine as follows : MgCl2: IL-2 and ~-
actin= 3mM; IL-3 and IFNy= 2mM; Primer concentration: IL-2 and IL-3= 30 
pmol; INFy= 20 pmol; ~-actin= 10 pmol. Amplification was done in a 
TempCyclerll thermocycler (Coy Lab. Inc., Ann Arbor, MI) as follows: hot start 
a t 95°C for 30 sec, followed by 25 cycles a t 94°C, 30 sec; ssoc, 30 sec; 72°C, 1 min. 
The PCR products were run on 2% agarose gels, visualized by ethidium 
bromide, and quantitated by scanning photograph negatives as described for 
Northern blots. 
Cytokine quantitation. Supernatants from macrophage cultures activated 
for 24 hr were used to quantitate IL-la, IL-6, and TNF. Supernatants from 
splenocyte cultures activated for 48 hr were used to quantitate IL-2, IL-3, and 
IFN-y. All supernatants were frozen and maintained at -70°C until assayed. All 
cytokines were quantitated by ELISA, using kits from either Genzyme 
Diagnostics, Cambridge MA (IL-la, IL-2, IL-6, TNF, and IFN-y) or Endogen, Inc., 
Cambridge, MA (IL-3) per manufacturer's instructions. 
Statistical methods. Data from these studies were analyzed by one-way 
analysis of variance (ANOV A) followed by the Fisher PLSD. Statistical 
calculations utilized Stat view TM SE +Graphics software from Abacus Concepts, 
Inc. 
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RESULTS 
Organ weight determination and cell counts revealed no effects of AFB1 
treatment on liver, kidney, spleen, or thymus weight or on red blood cell counts. 
The lowest dose (0.03 mg/kg body weight), however, caused a significant 
increase in the number of white blood cells when compared to the control 
groups. The medium dose, 0.145 mg/kg, also caused an increase in the number 
of white blood cells, but the increase was not significant. No marked changes in 
white blood cells were seen at the highest dose (0.7 mg/kg) (Table Il-l). 
The effect of AFB1 on IL-2, IL-3, and lFNy gene expression was determined 
by RT-PCR analysis of total mRNA extracted from splenic lymphocytes of 
treated and untreated animals, after 12 hr activation with ConA in vitro (Figs. ll-
1-3). AFB1 administered at the low dose of 0.03 mg AFB1 per kg body weight 
decreased the level of all three mRNAs, with IL-2 registering a significant 
difference (p_:::O.OS) from the control groups (Fig. Il-l). No significant difference 
in IL-2, lL-3, and IFNy mRNA was found between control groups and animals 
treated at the medium (0.145 mg AFB1/kg body weight) or high (0.7 mg 
AFB1/kg body weight) dose levels. The levels of P-actin mRNA were similar in 
all the groups. 
Interleukin-la, IL-6, and TNF gene expression in thioglycolate-broth-
stimulated, AFB1-treated and control animals was determined by Northern blot 
analysis (Figs. II-4-6). Total mRNA was extracted from macrophages after 6 hr 
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TABLE 11-1 
Selected organ weights and blood cell counts of CD-1 mice exposed to AFB1 
for two weeks a 
Organs (g/100 g body weight) 
_____________________________ RBC WBC 
AFB1 
( mg/ kg) Liver Kidney Spleen Thymus (x10•j mm3) (x10•j mm3) 
0 6.05 ± 0.23 1.69 ± 0.11 0.28 ± 0.02 0.28 ± 0.03 8.26 ± 0.43 8.20 ± 0.53 
0.03 6.22 ± 0.40 1.62 ± 0.05 0.28 ± 0.02 0.28 ± 0.02 7.94± 0.12 12.36 ± 1.50* 
0.145 6.15 ± 0.28 1.73 ± 0.12 0.34 ± 0.03 0.34 ± 0.02 7.98 ± 0.09 10.63 ± 0.49 
0.7 5.73 ± 0.15 1.73 ± 0.06 0.27 ± 0.03 0.34 ± 0.03 7.94 ± 0.50 9.32 ± 1.25 
a Values are given as mean± S.E., n=S. 
*Significantly different from the control valve (p < 0.05). 
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FIG. Il-l. Effect of AFB1 on the Con A-induced IL-2 expression. Total RNA 
(1 ~)of the Con A-activated (5 ~/2x1()6 cells for 12 hr) splenocytes from 
control and AFB1-treated mice were used to make eDNA and amplified by 
RT-PCR using murine IL-2 and murine j>-actin primers(A). Band densities 
from five different animals were measured from the negatives of the 
ethidium bromide stained 2% agarose gels by Zero D-scan. Values of the 
total PCR product per lane were measured and equalized using j>-actin 
standards, and the total IL-2 PCR product in the treated groups was calcu-
lated as percent of control values(B). Data points were mean± S. E. (n=5). 
(*) Differences significant at p ~ 0.05 level. 
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FIG. 11-2. Effect of AFB1 on the Con A-induced IL-3 expression. Total RNA 
(1~-tg) of the Con A-activated (5~-tg/2xHJ6 cells for 12 hr) splenocytes from 
control and AFB1-treated mice were used to make eDNA and amplified by 
RT-PCR using murine IL-3 and murine [3-actin primers (A). Band densities 
from five different animals were measured from the negatives of the 
ethidium bromide stained 2% agarose gels by Zero D-scan. Values of the 
total PCR product per lane were measured and equalized using [3-actm 
standards, and the total IL-3 PCR product in the treated groups was 
calculated as percent of control values (B). Data points were 
mean± S. E. (n=5). 
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FIG. II-3. Effect of AFB1 on the Con A-induced IFNyexpression. Total RNA 
(1 J.Jg) of the Con A-activated (5 J.Jg/2xl(J6 cells for 12 hr) splenocytes from 
control and AFB1-treated mice were used to make eDNA and amplified by 
RT-PCR using murine IFNyand murine j3-actin primers(A). Band densities 
from five different animals were measured from the negatives of the 
ethidiurn bromide stained 2% agarose gels by Zero D-scan. Values of the 
total PCR product per lane were measured and equalized using j3-actin 
standards, and the total IFNyPCR product in the treated groups was 
calculated as percent of control values(B). Data points were mean ±S. E. 
(n=5). 
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FIG. 11-4. Effect of AFB1 on the LPS -induced IL-1a expression. Total RNA 
(10 j.!g) of the LPS- activated (10 !lg/lx106 cells for 6 hr) peritoneal 
macrophages from control and AFB1- treated mice were analyzed by 
Northern blot using murine IL-1a and human ~actin 32P-labeled 
riboprobes {A). Band densities from three different animals were measured 
by Zero D-scan. Values of the total RNA per lane were measured and· 
equalized using ~actin standards, and the total IL-1amRNA in the treated 
groups was calculated as percent of control values(B). Data points were 
mean± S. E. (n=3). (*) Differences significant at p $. 0.05 level. 
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FIG. 11-5. Effect of AFB1 on the LPS -induced TNF expression. Total RNA 
(10 ~-~g) of the LPS- activated (10 ~g/lx106 cells for 6 hr) peritoneal 
macrophages from control and AFB1- treated mice were analyzed by 
Northern blot using murine TNF and human ~-actin 32P-labeled 
riboprobes (A). Band densities from three different animals were measured 
by Zero D-scan. Values of the total RNA per lane were measured and· 
equalized using ~-actin standards, and the total TNF mRNA in the 
treated groups was calculated as percent of control values (B). 
Data points were mean± S. E. (n=3). (*) Differences significant at 
p .::;. 0.05 level. 
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FIG. II-6. Effect of AFB1 on the LPS -induced IL-6 expression. Total RNA 
(10 J.lg) of the LPS- activated (10 !J.g/lx106 cells for 6 hr) peritoneal 
macrophages from control and AFB1- treated mice were analyzed by 
Northern blot using murine IL-6 and human ~-actin 32P-labeled 
riboprobes (A). Band densities from three different animals were measured 
by Zero D-scan. Values of the total RNA per lane were measured and· 
equalized using ~-actin standards, and the total IL-6 mRNA in the treated 
groups was calculated as percent of control values (B). Data points were 
mean± S. E. (n=3). (*)Differences significant at p .$. 0.05 level. 
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LPS induction in vitro. The results show a significant increase in IL-la mRNA in 
animals treated with AFB1 at low dose (Fig. Il-4). The medium dose level groups 
show a significant increase in both TNF (Fig. II-5) and IL-6 (Fig. Il-6) mRNA 
levels, while the high dose groups show a significant suppression of both IL-la 
and TNF (Figs. II-4, 5). No marked difference in the levels of P-actin was 
observed in any of the groups. 
The effect of AFB1 on the cytokine protein products was analyzed by 
ELISA. The supernatants of splenocyte cultures from treated and untreated 
animals were collected after 48 hr activation with Con A and used to quantitate 
IL-2, IL-3, and IFNy. Figs. Il-7-9 show that for all three cytokines, AFB1 treatment 
at all dose levels had no significant effect on the amount of protein secreted into 
the supernatant. 
The pattern of protein production follows closely that observed for mRN A 
levels, i.e., a slight decrease of protein is observed at low dosage in all three 
cytokines, followed by a recovery to normal levels at medium and high dose 
levels. The only exception is IL-2, where a decrease in mRNA at low dosage is 
significant while the protein levels, although also suppressed, do not appear to 
be significantly different from the controls. 
Similar ELISA analysis was performed for IL-la, IL-6, and TNF using the 
supernatant from macrophage cultures after LPS induction for 24 hr in vitro 
0 0.03 0.145 0.7 
AFB, (mg/ kg body weight) 
Fig. II-7. Effect of AFB1 on IL-2 production. Splenocytes 
(2xl()6 /rnl) from control and AFB1-treated mice were activated 
with 5 f.lg/ml Con A for 48 hrs. lnterleukin-2 in culture supernatants 
was detected by ELISA. Data were mean ±S. E. (n=4). 
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Fig. II-8. Effect of AFB1 on IL-3 production. Splenocytes 
(2x106/ml) from control and AFB1-treated mice were activated 
with 5~-~g/ml Con A for 48 hrs. Interleukin-3 in culture supernatants 
was detected by ELISA. Data were mean± 5. E. (n=4). 
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Fig. II-9. Effect of AFB1 on IFNyproduction. Splenocytes 
(2x106/ml) from control and AFB1-treated mice were activated 
with 5 J.tg/ml Con A for 48 hrs. Interferon yin culture supernatants 
was detected by ELISA. Data were mean ±S. E. (n=4). 
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(Figs. 11-10-12). A dramatic decrease in IL-1a was observed after treatment at all 
dose levels of AFB1, and the suppression was significant when compared to the 
control groups (p_:::O.OS) (Fig. II-10). A significant suppression of TNF and IL-6 
was also observed, but only at the highest dose of AFB1 (Figs. II-11, 12). 
In contrast to IL-2, IFNy, and IL-3, where the levels of mRNA and protein 
seem to be closely correlated after all levels of AFB1 treatment, IL-1a, IL-6, and 
TNF mRNA and protein levels do not appear to be closely correlated. Messenger 
RNA appears to be superinduced at the low (IL-1a) or medium (IL-6 and TNF) 
dosage of AFB1, but this superinduction does not translate into increased 
amounts of cytokines secreted into the medium. In fact, there seems to be a 
generalized suppression of cytokine secretion at all treatment levels, with the 
effect being most significant for IL-1a. Thus it appears that AFB1 treatment 
preferentially affects macrophage functions, and, in particular, it decouples the 
close correlation usually observed between transcriptional and translational 
controls of IL-1a, IL-6 and TNF production by these cells. 
DISCUSSION 
This study used male CD-1 mice to describe the in vivo effects of AFB1 on 
the genetic expression and production of several cytokines that modulate 
activation and proliferation of splenic lymphocytes and macrophages. Its 
under! ying assumptions are that AFB1 exerts its irnrnunotoxic effects by 
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Fig. II-10. Effect of AFB1 on IL-1a production. BIG-stimulated 
peritoneal macrophages (lx106 /ml) from control and AFB1-treated 
mice were activated with 10 ~/ml LPS for 24 hrs. Interleukin-1a 
in culture supernatant was detected by ELISA. Data were mean ± S. E. 
(n=3). (*) Significant difference at 0.05 level between treatment and 
control groups. 
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Fig. II-11. Effect of AFB1 on TNF production. BTG-stimulated 
peritoneal macrophages (1x106 /ml) from control and AFB1-treated 
mice were activated with 10 J.!g/ml LPS for 24 hrs. Tumor necrosis 
factor in culture supernatant was detected by ELISA. Data were mean 
± S. E .(n=3). (*)Significant difference at 0.05 level between treatment 
and control groups. 
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Fig. II-12. Effect of AFB1 on IL-6 production. BIG-stimulated 
peritoneal macrophages (1x106 /ml) from control and AFB1-treated 
mice were activated with 10 J.Jg/ml LPS for 24 hrs. Interleukin-6 in 
culture supernatant was detected by ELISA. Data were mean± S. E. 
(n=3). (*)Significant difference at 0.05 level between treatment and 
control groups. 
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alterating cytokine production in these cells and that analysis of the nature of 
those alterations will shed light on the molecular mechanisms involved in the 
toxin-induced immunosuppression. 
The doses and duration of the AFB, exposure used in this study did not 
seem to be toxic as they did not affect the liver, kidney, thymus and spleen 
weights as described in previous reports (Reddy et al. , 1987; Reddy and Sharma, 
1989; Dugyala et al., 1994). There was no effect on the erythrocyte counts but 
there was a significant elevation in the leukocyte counts at low dose (0.03 mg 
AFB,/kg body weight), which was also observed in an earlier study (Dugyala et 
al., 1994); this suggests that the doses of AFB, used in this study also have minor 
sub-clinical effects. 
The levels of IL-2, IL-3, and IFNy protein secreted in the medium by Con 
A-treated lymphocytes corresponded in general to their respective mRNA levels 
but did not differ significantly from untreated control values, with the exception 
of IL-2 mRNA, which is suppressed significantly in the low-dose groups. 
Although not statistically significant, there was a general reduction of all three 
cytokine mRNA and protein levels at low dose. This is interesting in light of the 
fact that aflatoxin is known to affect cell-mediated immunity (i.e., suppression of 
delayed-type hypersensitivity, natural killer activity, and T-helper cell functions) 
in mice at low and repeated doses (Reddy et al., 1987; Reddy and Sharma, 1989). 
Hatori et al. (1991) observed that C57B1/6 mice treated with similar doses used 
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in this study, showed a decrease in IL-2 production in the highest-dose-trea ted 
group and no effect in other AFB1-treated groups. The discrepancy may be due 
to their use of a 4-week exposure instead of 2 weeks used in the present study. 
A number of factors may have caused the observed reduction in IL-2 and 
IFNy mRNA and protein levels at low doses of AFB1. CD4+ T cells are 
subdivided into two distinct subsets based on the pattern of lymphocyte 
secretion; TH1 cells produce IL-2 and IFNy (and other cytokines) but not IL-4, IL-
5, IL-6, and IL-10, and are involved in cell-mediated immune responses. TH2 
cells produce IL-4, IL-5, IL-6, and IL-10, but not IL-2 and IFNy, and are involved 
in antibody-mediated immune responses (Mosmann and Coffman, 1989). IL-3 is 
produced by both types of cells. Emergence of the dominant subset ofT-helper 
cells is dependent on the induction of specific cytokine profiles during the 
immune response. For example, macrophages, especially when infected by 
intracellular bacteria, are potent inducers of IL-12, directing the T-helper cell 
development toward TH1 responses (Hsieh el al., 1993). In the absence of a 
source of high concentration of IL-12, production of IL-4 by subsets of CD4+ T 
cells may prevent TH1 cell development and the production of cytokines (Gollob 
and Coffman, 1994; Yoshimato and Paul, 1994). Interleukin 10 produced by the 
TH2 cells, acting in conjunction with antigen presenting cells, also inhibits the TH1 
production of IFNy and IL-2 (Fiorentino et al ., 1989). Cholera toxin, cyclosporin 
A, 8-Br-cAMP, and prostaglandin E2 are also known to preferentially inhibit TH1 
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cell-produced cytokines through their unique T cell receptor-associated signal 
transduction pathways (Gajewski et al., 1990; Munoz et nl., 1990; Betz and Fox, 
1991). Activation of RNA and protein synthesis in mouse splenocytes was 
observed in the low dose exposure to AFB1 in BALB/c mice for 4 weeks (Reddy 
and Sharma, 1989). Activation of protein synthesis was also detected in CD-1 
mice exposed for 2 weeks (Reddy et al., 1987). Therefore, the low-dose inhibition 
of IL-2 and IFNy observed in this study may be due to activation of any of the 
above-discussed factors, which results in the suppression of THl cytokine 
products. Further studies are needed to explore these mechanisms of 
immunomodulation and the nature of TH1/TH2 cell subsets in CD4+ T cell 
population during AFB, exposure. 
The levels of IL-la, IL-6, and TNF protein secreted by LPS-stimulated 
macrophages varied significantly from the controls; IL-6 and TNF levels were 
reduced significantly at high dosages, and IL-1a at all dosages administered. 
The fact that the mRNA levels did not correspond to those of the proteins at the 
low and medium dosages indicates a breakdown of the usual transcriptional 
regulation of these cytokines. In the high-dose-treated animals, both mRNA and 
protein decreased, significantly so for IL-la and TNF. The results show that 
AFB1 suppresses IL-la gene expression and regulation transcriptionally in high 
dose groups and more strongly at the post-transcriptional level in all dose 
groups. Interleukin-la and IL-lP do not possess a typical NH2-terminal 
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hyd rophobic secretory signal sequence responsible for translocation of the 
proteins directly into the endoplasmic reticulum via the classic exocytic secretory 
pathway (Giri et al., 1985). As a consequence, the newly synthesized IL-1a 
precursor protein is localized in the cytoplasm where it is cleaved by the 
proteolytic enzyme calpain; subsequently it undergoes a conformational change 
that exposes the required secretory signal to be secreted out upon an activation 
signal (Carruth et al., 1991; Hazuda et al., 1991; Siders et al. , 1993). Aflatoxin B1 
may affect any of the above discussed processes; it may inhibit the proteolytic 
enzyme or the subsequent events leading to the secretion of IL-1a. Pentamidine, 
an aromatic diamidine currently used to treat Pneumocystis carinii, specifically 
inhibits the cleavage of pro-IL-1a and its secretion (Rosenthal et al., 1991). 
Even though protein levels of IL-6 and TNF are not suppressed 
significantly, the fact that they do not correlate with the increased mRNA levels 
in the medium dose groups and the decreased protein levels in the high dose 
group shows that AFB, may affect some of the general translational machinery of 
the cell or its secretory pathway. Direct damage to the endoplasmic reticulum 
membranes, interference with the ribosome binding sites, interference with the 
ribosomal cycle, and inhibition of the release of newly synthesized proteins that 
may affect the ER-mediated protein synthesis are all alterations that have been 
observed during AFB1 exposure (Terao and Ueno, 1978; Viviers and Schabort, 
1985). 
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The significant changes observed in mRNA and protein levels for all three 
cytokines may be due to the differential regulation of factors responsible for 
transcription or mRNA stability by AFB1. Aflatoxin B1 has the property of 
binding to the macromolecules via the formation of AFB1-8,9 epoxide and, to a 
lesser extent, its hydration product, the dihydrodiol form. The epoxide 
specifically makes an electrophilic attack on the N7 position of guanine in DNA 
and RNA (Croy eta/., 1978; Essigman eta/. , 1980; Croy and Wogan, 1981a, b; 
Benasutti et al., 1988), while the dihydrodiol forms a schiff base with amino 
groups of the bases (Hsieh, 1987). The inhibitory effects of AFB1 may be on the 
DNA template activity and RNA polymerase II, an enzyme largely responsible 
for mRNA synthesis (Yu, 1977). AFB1 also interferes with RNA chain elongation 
(Yu, 1981). 
The elements in the 5' regulatory regions including glucocorticoid 
regulatory elements, NFKB, AP-1 binding sites, and NF-IL-6 have been shown to 
be involved in the transcriptional regulation, whereas AUUUA sequences in the 
3'-untranslated region are the sites of cytosolic protein associations that 
stabilize/ degrade the cytokine mRNA and regulate the stability and 
translational efficiency (Caput eta/., 1986; Shaw and Karmen, 1986; Brown and 
Beutler, 1990; Natsuka eta/., 1992; Henics eta/., 1994). Protein kinase C enhances 
the removal of poly (A) from TNF mRNA, thereby faci litating the early mRNA 
degradation (Lieberman et a/., 1992). Phorbol esters and calcium ionophores 
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have been. shown to stabilize IL-2 mRNA via protein kinase C (PKC)-dependent 
phosphorylation as it is blocked by the inhibitors of PKC, such as staurosporine 
and K252a (Ohmura and Onoue, 1990). Moreover, the addition of an inhibitor of 
serine/ threonine protein phosphatases (i.e., okadiac acid) resulted in increased 
instability of IL-2 mRNA, which further supports that protein phosphorylation 
plays an important role in the mRNA stability (Ohmura and Onoue, 1990). All 
these events require de novo protein synthesis, which can be altered by the AFB1. 
Immunosuppressant drugs such as FK506 and rapamycin inhibit mRNA stability 
of cy tokines by a mechanism involving PKC-regulated AUUUA-specific binding 
proteins (Tocci et al., 1989; Hanke et al., 1992). There is evidence that AFB1 binds 
to the cytoplasmic molecules destined for the nucleus (Ch'ih ami Devlin, 1984; 
Ch'ih et al., 1993). Moreover, AFB1 preferentially binds to the physiologically 
active regions of the nucleolar chromatin of rat liver cells (Yu, 1983). A decrease 
of mRNA induction of IL-1a and TNF and no effect on mRNA of IL-6 may be 
due to their differences in the time of expression and regulation (Akira et al., 
1990). Whether any of these processes are affected by AFB1 in the immune cells 
needs to be further investigated. 
Among the cytokines analyzed, IL-1a seems to be more sensitive to AFB1 
at all dose levels tested than IL-6 and TNF; this shows that the mechanism of 
action of AFB, is specific. Interleukin 1a is the most abundantly produced 
cytokine in mice; its level is above that of IL-1P. It plays a very important role in 
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immune regulation; together with IL-6 and TNF, it plays a pivotal role in cell-
mediated immunity, as well as in the regulation of inflammation and 
hematopoiesis (Rosenthal et al., 1991; Dinarello, 1992). Interleukin-1 amplifies T 
cell activation by inducing IL-2 and IL-2R gene expression, particularly in 
conjunction with antigens and mitogens (Dinarello, 1992). The activation of 
mature T cells by IL-l is dramatically increased in combination with IL-6, which 
shows that the two cytokines act synergistically (Dinarello, 1992). Tumor 
necrosis factor also plays a role in the development of cell-mediated immunity by 
inducing the cytotoxic T lymphocytes and generating IL-2 and IL-12 (Fiers, 1991). 
Based on the present investigation, AFB1 seems to affect cell-mediated immunity 
mainly by affecting the macrophage-producing cytokines. The results would be 
an inhibition of the signals activating THl cells to respond to foreign antigen. It 
does not seem to have much effect on THl cytokine production in spite of the 
slight decrease in production of Con A-induced cytokines by splenocytes in the 
low-dose-treated groups. 
The observations strengthen the conclusion that AFB, main effects are on 
the macrophages. Various studies have shown that aflatoxin inhibits 
macrophage functions such as phagocytic, chemotactic, microbicidal, and 
adherence activity (Chang and Hamilton, 1979; Neldon-Ortiz and Qureshi, 1991; 
Jakab et al., 1994; Cusumano et al. , 1995). These impaired functions of 
macrophages will definitely affect the first line of defense against infectious 
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diseases (Skamene and Gros, 1983). More importantly, macrophages take up 
and process foreign substances and present the derived antigens to lymphocytes, 
as well as secrete cytokines, which are important for the development of 
acquired immunity (Unanue, 1984). By adding the present results to other 
studies, the conclusion that AFB1 mainly affects cell-mediated immunity via 
inhibition of macrophage functions is warranted. 
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CHAPTER III 
ALTERATION OF KEY CYTOKINES PRODUCED BY MITOGEN-
ACTIVATED PERITONEAL MACROPHAGES AND 
SPLENOCYTES IN T-2 TOXIN-TREATED 
MALE CD-1 MICE 
ABSTRACT 
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Male CD-1 mice were used to study the effect of in vivo exposure to T-2 
toxin on the alteration of IL-1a, TNF, and IL-6 cytokines in LPS-stimulated 
peritoneal macrophages, and IL-2, IL-3, and IFNy cytokines in Con A-stimulated 
splenocytes. Mice received 0, 0.1, 0.5, and 2.5 mg T-2 toxin/kg body weight 
orally for 2 weeks on alternate days. Northern blot analysis of IL-1a, TNF, and 
IL-6 mRNA from activated peritoneal macrophages showed no significant 
differences between control and treated groups. ELISA measurements of 
secreted protein demonstrated suppression of these cytokines in all groups when 
compared to the controls. Thus T-2 toxin appears to affect the translational or 
post-translational regulation of cytokines from peritoneal macrophages. IL-2, IL-
3, and IFNy mRNA levels from Con A-activated splenocytes were higher in all 
treated groups; the increases were significant for IL-2 and IFNy in the groups 
receiving low (0.1 mg/ kg) and high (2.5 mg/ kg) doses of T-2 toxin, and for IL-3 
in the group receiving a medium (0.5 mg/kg) dose of this toxin (p~ 0.05). The 
88 
data indicate that T-2 toxin at low or medium doses induces transcription or 
increases mRNA stability of IL-2, IFNy, and IL-3. The protein levels of all three 
cytokines were also increased significantly; for IL-2 and IFNy at the low dosage, 
and for IL-3 at low and medium dosages, indicating that T-2 toxin also increases 
translational/ post-translational efficiency of all three cytokines. The possible 
mechanisms involved in the immunosuppressive effects of T-2 toxin are 
discussed relative to these findings. 
INTRODUCTION 
T-2 toxin [12, 13-epoxytrichothec-9-ene-3, 4, 8, 15-tetrol 4, 15-diacetoxy-8-
(3-methyl-butanoate)] is one of the many trichothecene mycotoxins produced by 
several genera of fungi, particularly the Fusarium species. It causes severe 
human and animal diseases such as alimentary toxic aleukia and 
stachybotriotoxicosis, affecting the mucosa and the immune system. 
Leukopenia, anemia, and bone marrow aplasia are the most common 
pathological symptoms of these diseases (Sharma and Kim, 1991). T-2 toxin has 
systemic effects on nearly every major organ system, including cardiovascular, 
central nervous system, bone marrow, liver, and the gastrointestinal tract in 
animals and humans (Ueno et al., 1973; Weaver et al., 1978; Hayes and Schiefer, 
1980; Hayes et al., 1980; Lusky and Mor, 1981; Ueno, 1983; Joffe, 1986; Pang et al., 
1987; Dugyala et al., 1991). 
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The immunotoxic potential of T-2 toxin in different animals has been 
reviewed and found to selectively affect various subpopulations of immune cells 
such as lymphocytes and macrophages (Sharma, 1993). Decrease of cytotoxicity, 
phagocytosis and chemotaxis were observed in human polymorphonuclear cells 
and rat alveolar macrophages when treated with T-2 toxin (Gerberick and 
Sorenson, 1983; Yarom et al., 1984). CD-1 mice exposed for 2 or 4 weeks to T-2 
toxin (0.02-5.0 mg/ kg body weight) showed a suppression of thymus-derived T 
cell mediated function and delayed-type hypersensitivity but normal T cell 
dependent antibody production and antibody-producing cells (Taylor et al., 
1985). These data indicate that T-2 toxin has a specific immunomodulatory 
effec t in mice. Some of the imrnunomodulatory effects of T-2 toxin are indirec t, 
acting via the hypothalamic-pituitary-adrenal (HPA) axis in mice (Taylor et al., 
1989; Taylor et al., 1991). T-2 toxin administred to pregnent mice has been found 
to specifically decrease prolymphoid cell populations in fetal thymus, liver and 
bone marrow cells (Holladay et al., 1993; Holladay et al., 1995). T-2 toxin has also 
been reported to lower lymphoid DNA and protein synthesis (Rosenstein and 
Lafarge-Frayssinet, 1983), and antibody synthesis (Rosenstein et al., 1979). In 
experimental models, T-2 toxin has also been reported to cause decreased 
resistance to mycobacterial infection (Kanai and Kondo, 1984), increased 
mortality after challenge with Salmonella species (Tai and Pestka, 1990), increased 
susceptibility to herpes simplex virus (Friend et al., 1983), and increased 
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mortality in listeriosis (Carrier et al., 1987). While it is known that T-2 toxin 
inhibits cellular protein, DNA, and RNA synthesis (Carrier and Ziprin, 1986; 
Mann et al., 1983; Lafarge-Frayssinet et al., 1981; Gyongyossy-Issa and 
Kachatourians, 1985; Gyongyossy-Issa et al ., 1986; Deloach et al., 1989), little is 
known about the mechanism involved in the immunomodulation. 
Understanding the mechanism of immunosuppression of T-2 toxin is very 
difficult due to its complex effects on the immune response in vivo, which are still 
obscure. Suppression may occur when a toxin affects the phagocytic and/or 
antigen-processing capacity of the macrophages, the antigen recognition ability 
of the lymphocytes, the differentiation and proliferation ofT and B lymphocytes, 
or the activation of immune effector mechanisms, including the production and 
release of cytotoxic lymphocytes, antibodies, and/or delayed hypersensitivity 
mediators. Since cytokines affect all the above-mentioned processes directly or 
indirectly, it is only logical that T-2 toxin may produce its immunomodulatory 
effects through interference with the production of cytokines in macrophages 
and T lymphocytes. Few studies have investigated cytokine (IL-2) production 
and T-2 toxin exposure (Holt et al., 1988b). In the present study, mRNA and 
protein levels for several key cytokines were determined in macrophages (IL-la, 
lL-6, and TNF) and splenic lymphocytes (IL-2, IFNy, and IL-3) after exposure of 
CD-1 mice to various doses of T-2 toxin in vivo. The cytokines were selected on 
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the basis of their known importance in the regulation of acquired immunity 
(Akira et nl. , 1990; Paul and Sedar, 1994). 
MATERIALS AND METHODS 
Animals. Male CD-1 mice, 5 weeks old, were obtained from Charles River 
Laboratories (Wilmington, MA). Mice were acclimatized for 7 days in a 
temperature-controlled (22 ± 1 °C, 50% relative humidity) and artificially 
illuminated room (12 hr light cycle) of an AAALAC-accredited animal care 
facility. Pelleted feed (toxin free) and fresh water were provided ad libitum. 
T-2 toxin exposure. T-2 toxin was obtained from Sigma Chemical Co. (St. 
Louis, MO) and dissolved in a corn oil:ethanol (95:5) vehicle just before 
administration. Two sets of mice were separated into four groups (control, low, 
medium, and high dose) and were dosed with 0, 0.1, 0.5, or 2.5 mg T-2 toxin/ kg 
body weight, respectively. T-2 toxin was administered by oral gavage every 
other day for 2 weeks (seven doses). Body weights were recorded daily 
throughout the experimental period. Mice were euthanized by carbon dioxide 
after 48 hr of the final dose. From one set of animals, the livers, thymus, kidneys, 
and spleens were removed and weighed and the blood was collected in 
heparinized tubes for red and white blood cell counts. The spleens were 
removed asceptically and used as a source of splenocytes. Macrophages were 
isolated from the second set of animals by intraperitoneal lavage. 
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Isolation and activation of splenic lymphocytes. The asceptically 
collected spleens were maintained in cold complete RPM! [RPMI-1640 (Gibco, 
Grand Island, NY), 2 mM glutamine, 100 units/ml penicillin, 100 mg/ ml 
streptomycin, 50 mM 2-mercaptoethanol, 10% heat inactivated fetal calf serum 
(FCS) (Hyclone Lab., Logan, UT)] . Monocellular cell suspensions were prepared 
using a Stomacher lab blender (STOM 80, Tekmar Co., Cincinnati, OH) . Red 
blood cells were removed with ACK lysing buffer (0.15 M NH4Cl, 1 mM 
KHC03, 0.1 mM Na2EDT A, pH 7.4). The remaining cells were plated in Falcon 
100 mm plates and incubated at 37°C for 1 hr to allow adherence of 
macro phages. The nonadherent cells were collected, counted by automatic blood 
cell counter (Coulter Electronic Inc., Hialeah, FL), adjusted to a concentration of 2 
x 106/ ml, activated with 5 mg/ ml concanavalin A (Con A) (Sigma) in complete 
RPM!, and replated 15- 20 ml/ plate in 100-mm Falcon culture dishes for 12 or 48 
hr. 
Isolation and activation of macrophages. For macrophages, animals 
were injected intraperitoneally with 3 ml of 3% Brewers thioglycolate broth 
(BTG) (Gibco). On the fourth day post injection, peritoneal lavage was 
performed with 5 ml ice-cold complete RPM!+ 10 U/ml heparin. Macrophages 
were counted in a hemocytometer, adjusted to 106 cells/ml in complete RPM! 
medium, and 5 ml of the cell suspension were plated in 60-mm dishes. To 
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activa te the cells, lipopolysaccharide (LPS) (Sigma) was added to each plate at a 
concentration of 10 mg/ ml and cultured for 6 or 24 hr. 
Total RNA isolation and analysis. Total RNA was extracted from 
lymphocytes after 12 hr activation with Con A and from macrophages after 6 hr 
activation with LPS. The lymphocytes were harvested by centrifugation and 
total RNA was extracted from the pellet with TRl REAGENT™ LS (Molecular 
Research Ctr., Cincinnati, OH) per manufacturer's protocol. RNA from 
macrophages was extracted by removing the medium and applying TRI reagent 
LS to the adherent cells on the plate following manufacturer's instructions. The 
purified RN As were suspended in FORMAzol (Molecular Research) and stored 
Northern analysis of IL-Ia, IL-6, and TNF and control (3-actin was done 
using antisense riboprobes labeled with 32P-UTP or 32r-CTP to a specific activity 
?,3 x 108 cpm. Antisense transcripts were generated using cloned cDNAs and the 
bacteriophage T3 or T7 RNA polymerase (Promega, Madison, WI), per 
manufacturer's instructions. Template cDNAs were as follows: for IL-1, ATCC 
clone #63106 in pBluescript SK+, cut with Hind III, transcribed with T3; for IL-6, 
800 bp eDNA clone (Pst I ends) in pBluescript II KS+, cut with Hind III, 
transcribed with T7; for TNF, 1230 bp eDNA clone (Eco Rl ends), cut with Hind 
Ill, transcribed with T7. The latter two clones were obtained from Dr. A. D. 
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Weinberg (Univeristy of California, San Diego, CA). Human ~-actin used as 
control was from ATCC, clone #78554 cut with Hind Ill, transcribed with T3. All 
the clones were sequenced from both ends and found to conform to respective 
eDNA sequences in Genbank. 
Ten micrograms of total RNA were fractionated through a 1.2% agarose 
gel containing 1.1 % formaldehyde. The RNAs were transferred to MAGNA NT 
ny lon membranes (Micron Separations Inc. Westboro, MA). The membranes 
were stained with 0.02% methylene blue and photographed, and the positions of 
18S and 285 ribosomal RNA bands and RNA ladder size markers was noted on 
the membrane and later used for sizing and estimation of total RNA loaded per 
lane. Prehybridization (approx. 1 hr) and hybridization at 57°C (16 to 24 hr) 
were carried out in buffers containing 50% formamide and the membranes were 
washed under high stringency conditions per manufacturer's protocols. The 
blots were exposed for 6 hr to overnight to Kodak X-AR film a t -70°C with 
Dupont Lightning Plus screens. The bands were quantitated by scanning their 
densities using ZERO-D scan software program (Stratagene Cloning Systems, La 
Jolla, CA). Total RNAs per lane were adjusted with the ~-actin bands and 
percentage of change in cytokine RNA levels in mycotoxin- treated mice were 
calculated using control values set at 1. 
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IL-2, IL-3, and IFNy and ~-actin were analyzed by reverse transcriptase-
polymerase chain reaction (RT-PCR) using Oligo 4.0-software-selected primer 
sets for each sequence as follows: 
IL-2 (611 bp): Sense= 5'-GCGCACCCACTTCAAGCTCC-3' 
Antisense= 5' AGCCCTTGGGGCTT ACAAAA-3' . 
IL-3 (567 bp): Sense= 5'-CCCTTGGAGGACCCAGAAC-3'; 
Antisense= 5'-GCCATGAGGAACA TTCAGAC-3'. 
lFNy (510 bp): Sense= 5'-GTTCTGGGCTTCTCCTCCTG-3'; 
Antisense= 5'-CGAA TCAGCAGCGACTCCTT -3'. 
~-actin (265 bp): Sense=AACACAGTGTTGTCTGGTGG-3'; 
Antisense= 5'-ACGCAGCTCAGT AACAGTCC-3' 
For first-strand synthesis, 1 !lg of lymphocyte total RNA and 0.5 !lg oligo 
(dTh2-18 (GibcoBRL) were mixed in a 20 f!l total volume reaction containing 50 
mM Tris-HCI (pH8.3@RT), 75 mM KCI, 3 mM MgCl2, 10 mM OTT, 0.5 mM each 
dATP, dCTP, dGTP, and dTTP (Promega), and 200U SuperScript II RNase H- RT 
(GibcoBRL) and incubated at 42°C for 50 min. After heating at 70°C for 15 min, 
the mixture was chilled in ice, and 2 units of RNaseH (Boehringer Mannheim, 
Indianapolis, IN) were added, followed by a 20-min incubation at 37°C. Twenty 
microliters of sterile double-distilled water was then added to the eDNA and 2f!l 
of the diluted samples were used for each polymerase chain reaction. The 
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optimal MgCI2 and primer concentra tions in a PCR reaction were determined 
empirically for each cytokine as follows: MgCI2: IL-2 and ()-actin= 3mM; IL-3 and 
IFNy= 2mM; Primer concentration: IL-2 and IL-3= 30 pmol; IFNy= 20 pmol; P-
actin= 10 pmol. Amplification was done in a TemCyclerll thermocycler (Coy 
Lab. Inc. , Ann Arbor, MI) as follows: hot start at 95°C for 30 sec, followed by 25 
cycles a t 94°C, 30 sec; 55°C, 30 sec; 72°C, 1 min. 
The amplification products were run on 2% agarose gels, visualized by 
ethidium bromide staining, photographed using Polaroid 667 fi lm, and 
quantitated by scanning the negatives as described for Northern blots. 
Cytokine quantitation. Supernatants from macrophage cultures activated 
for 24 hr were used to quantitate IL-Ia, IL-6, and TNF. Supernatants from 
splenocyte cultures activated for 48 hr were used to quantitate IL-2, IL-3 and IFN 
yAll supernatants were frozen and maintained at -70°C until assayed. All 
cytokines were quantitated by ELISA, using kits from either Genzyme 
Diagnostics, Cambridge, MA (IL-l a, IL-2, IL-6, TNF, and IFNy) or Endogen, Inc., 
Cambridge, MA (IL-3) per manufacturer's instructions. 
Statistical methods. Data from these studies were analyzed by one-way 
analysis of variance (ANOV A) followed by the Fisher PLSD. Statistical 
calculations utilized Stat view TM SE + Graphics software from Abacus Concepts, 
Inc. 
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RESULTS 
Organ weight determination and cell counts revealed a significant 
reduction in thymus weight at all doses of T-2 toxin (Table III-1). In contrast, 
significant higher values were noted in the weight of the spleen at the medium 
(0.5 mg T-2 toxin/kg body weight) and high (2.5 mg T-2 toxin/kg body weight) 
doses, and in the liver at the high dose. In addition, a significant increase in 
white blood cell counts occurred at the medium dose, and a significant reduction 
of red blood cells at the high dose of T-2 toxin. Kidney weights were unaffected 
at all doses administered. Thus, it appears that the mycotoxin has an effect in all 
immunogenic systems measured, the type and extent depending on the dosage. 
The thymus seems to be particularly sensitive to the effect of the toxin. 
The effect of T-2 toxin on IL-2, IL-3, and IFNy gene expression was 
determined by RT-PCR analysis of total mRNA extracted from splenic 
lymphocytes of treated and untreated animals, after 12 hr activation with LPS in 
vitro (Figs. III-1-3). IL-2 and IFNy mRNA were significantly increased at the low 
and high concentrations of the toxin. There was also an increase of these mRNAs 
at the medium dose level, but the increase was not significant (Figs. III-1 and 3). 
IL-3 mRNA levels were increased, significantly from the control groups only at 
the medium dose of the toxin (Fig. III-2). The levels of P-actin mRNA were 
similar in all the groups. 
TABLE III-1 
Selected organ weights and blood cell counts of CD 1 mice exposed to 
T-2 toxin 
(mg/ kg) Liver 
T-2 toxin for two weeks a 
Organs (g/100 g body weight) 
Kidney Spleen 
RBC WBC 
0 5.77 ± 0.23 1.85 ± 0.12 0.30 ± 0.02 0.25 ± 0.02 8.33 ± 0.32 5.75 ± 0.30 
0.1 6.05 ± 0.10 1.65 ± 0.07 0.39 ± 0.01 0.19 ± 0.01 * 8.67 ± 0.13 6.19 ± 0.50 
o.s 6.13 ± 0.18 1.74 ± o.1o oAo ± o.o2* 0.20 ± o.o2· 8.37 ± o.23 6.69 ± o.s5* 
2.s 6.6o ± o.o8* 1.8o ± 0.10 0.48 ± o.o6* 0.14 ± o.o2* 7.16 ± o.24* 5.05 ± o.38 
n Values are given as mean± S.E.M., n=5 
*Significantly different from the control valve (p < 0.05) 
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FIG. III-1. Effect of T-2 toxin on the Con A-induced IL-2 expression. 
Total RNA (111g) of the Con A-activated (Silg/2x106 cells for 12 hr) 
splenocytes from control and T-2 toxin-treated mice were used to 
make eDNA and amplified by RT-PCR using murine IL-2 and murine 
!3-actin primers( A). Band densities from three different animals were 
measured from the negatives of the ethidium bromide stained 2% 
agarose gels by Zero D-scan. Values of the total PCR product per lane 
were measured and equalized using !3-actin standards, and the total 
IL-2 PCR product in the treated groups was calculated as percent of 
control values(B). Data points were mean ±.S. E. (n=3). (*)Differences 
significant at p 5. 0.05 level. 
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FIG. Ill-2. Effect of T-2 toxin on the Con A-induced IL-3 expression. 
Total RNA (1 J.Jg) of the Con A-activated (5 J.Jg/2x1Q6 cells for 12 hr) 
splenocytes from control and T-2 toxin-treated mice were used to make 
eDNA and amplified by RT-PCR using murine IL-3 and murine !3-actin 
primers (A). Band densities from three different animals were measured 
from the negatives of the ethidium bromide stained 2% agarose gels 
by Zero D-scan. Values of the total PCR product per lane were measured 
and equalized using !3-actin standards, and the total IL-3 PCR product 
in the treated groups was calculated as percent of control values (B). 
Data points were mean± S. E. (n=3). (•) Differences significant at 
p 5. 0.05 level. 
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FIG. 111-3. Effect of T-2 toxin on the Con A-induced IFNyexpression. Total 
RNA (1 ~-~g) of the Con A-activated (5 ~-~g/ 2xl06 cells for 12 hr) splenocytes 
from control and T-2 toxin-treated mice were used to make eDNA and 
amplified by RT-PCR using murine IFNyand murine ~actin primers (A). 
Band densities from three different animals were measured from the 
negatives of the ethidium bromide stained 2% agarose gels by Zero D-scan. 
Values of the total PCR product per lane were measured and equalized 
using ~actin standards, and the total IFNyPCR product in the treated 
groups was calculated as percent of control values (B). Data points were 
mean ±. S. E. (n=3). (*) Differences significant at p ~ 0.05 level. 
101 
102 
Interleukin-la, IL-6, and TNF gene expression in thioglycolate-broth-
stimulated, T-2 toxin-treated and untreated animals was determined by 
Northern blot analysis utilizing the total mRNA extracted from macrophages 
after 6 hr LPS induction in vitro (Figs. ITI-4-6). There was a significant reduction 
in the number of peritoneal macrophages obtained from the high-dose group 
(Table rn-2); therefore, not enough total RNA became available for Northern 
analysis. For this reason, the total RNA extracted from three different animals in 
the high-dose group was pooled and trea ted as a single value; thus the results for 
that group could not be statistically evaluated. The medium and low dose 
groups show large variations and the values obtained for all three cytokines 
were not significantly different from the control groups. No marked difference 
in the levels of P-actin was observed among the groups. 
The effect of T-2 toxin on the cytokine protein production was analyzed 
by ELISA. The supernatants of splenocyte cultures from treated and untreated 
animals were collected after 48 hr activation with Con A and used to quantitate 
IL-2, IL-3 and IFNy. Figures Ill-7 to 9 show that all three cytokine protein levels 
increased in general at all doses administered; for IL-2 (Fig. III-7) and IFNy (Fig. 
III-9), these increases were significant at the low dosage only. For IL-3 (Fig. Ill-8), 
both the low and medium dosages registered a significant increase in protein 
secreted into the medium. 
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FIG. III-4. Effect of T-2 toxin on the LPS -induced IL-1a expression. 
Total RNA (10 ~)of the LP5-activated (10 ~/1x1()6 cells for 6 hr) 
peritoneal macrophages from control and T-2 toxin-treated mice were 
analyzed by Northern blot using murine IL-1a and human !)-actin 
32P-labeled riboprobes in separate experirnents(A). Band densities 
from three different animals were measured in medium and low dose 
groups and density from high dose group was measured from the 
mixture of three animals by Zero 0-scan. Values of the total RNA per 
lane were measured and equalized using !)-actin standards, and the 
total IL-1a rnRNA in the treated groups was calculated as percent of 
control values(B). •Data points are mean± S. E. (n=3) from medium 
and low dose group mice. "Single data point was from high dose group 
mice. 
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FIG. III-5. Effect of T-2 toxin on the LPS -induced TNF expression. 
Total RNA (10 J.Jg) of the LPS-activated (10 J.Jg/lx1Q6 cells for 6 hr) 
peritoneal macrophages from control and T-2 toxin-treated mice were 
analyzed by Northern blot using murine TNF and human 13-actin 
32P-labeled riboprobes in separate experiments(A). Band densities 
from three different animals were measured in medium and low dose 
groups and density from high dose group was measured from the 
mixture of three animals by Zero D-scan. Values of the total RNA per 
lane were measured and equalized using 13-actin standards, and the 
total TNF mRNA in the treated groups was calculated as percent of 
control values(B). •Data points are mean ±S. E. (n=3) from medium 
and low dose group mice. bSingle data point was from high dose group 
mice. 
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FIG. III-6. Effect of T-2 toxin on the LPS -induced IL-6 expression. 
Total RNA (10 J.Jg) of the LPS-activated (10 J.Jg / 1x106 cells for 6 hr ) 
peritoneal macrophages from control and T-2 toxin-treated mice were 
analyzed by Northern blot using murine IL-6 and human j3-actin 
32P-labeled riboprobes in separate experiments( A). Band densities 
from three different animals were measured in medium and low dose 
groups and density from high dose group was measured from the 
mixture of three animals by Zero 0-scan. Values of the total RNA per 
lane were measured and equalized using j3-actin standards, and the 
total IL-6 mRNA in the treated groups was calculated as percent of 
control values(B). •Data points are mean± S. E. (n=3) from medium 
and low dose group mice. bSingle data point was from high dose group 
mice. · 
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TABLE III-2 
Effect of T-2 toxin on the number of peritoneal 
macrophages in CD-1 mice when 
exposed for two weeks a 
T-2 toxin macro phages 
(mg/ kg) (x104/ ml) 
0 196.4 ± 31.23 
0.1 228.4 ± 23.00 
0.5 249.0 ± 9.30 
2.5 55.6 ± 8.70 * 
a Values are given as mean± S. E. (n=S). 
*Significantly different from the control values (p < 0.05) . 
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Fig. III-7. Effect of T-2 toxin on IL-2 production. Splenocytes 
(2x106 /ml) from control and T-2 toxin-treated mice were activated 
with 5 Jlg/ml Con A for 48 hrs. Interleukin-2 in culture supernatants 
was detected by ELISA. Data were mean± S. E. (n=4). (*) Significant 
difference at 0.05 level between treatment and control groups. 
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Fig. III-8. Effect of T-2 toxin on IL-3 production. Splenocytes 
(2x106 /ml) from control and T-2 toxin-treated mice were activated 
with 5 !lg/ ml Con A for 48 hrs. Interleukin-3 in culture supernatants 
was detected by ELISA. Data were mean ±S. E. (n=4). (*)Significant 
difference at 0.05 level between treatment and control groups. · 
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Fig. III-9. Effect of T-2 toxin on IFNyproduction. Splenocytes 
(2x1CJ6/ml) from control and T-2 toxin-treated mice were activated 
with 5~~g/ml Con A for 48 hrs. Interferon yin culture supernatants 
was detected by ELISA. Data were mean± S. E. (n=4). (*) Significant 
difference at 0.05 level between treatment and control groups. 
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At the low dosage, the pattern of protein production for IL-2 and INFy 
follows closely that observed for the corresponding mRNA levels (see Figs. Ill-1, 
3). At the medium and high dosages, the higher levels of both mRNA and 
proteins for these cytokines is maintained, but the protein values do not appear 
to differ singnificantly from the controls. IL-3 mRNA and protein levels both 
increase, and the increase is significant for the protein at the low and medium 
dosages of the toxin. In general, it seems that T-2 toxin treatment results in 
increases of both mRNA and protein levels for IL-2, IL-3, and IFNy, depending 
on the dose. The regulation of gene expression at the transcriptional level is 
maintained at low doses for IL-2 and IFNy, but not for IL-3, where protein levels 
secreted into the medium are significantly increased without a corresponding 
increase in mRNA. At the medium and high doses, the correspondence between 
mRNA and protein levels is further broken down for all three cytokines, but all 
register increases in both mRNA and protein levels when compared to the 
control groups. 
Similar ELISA analysis was performed for IL-1a, IL-6, and TNF using the 
supernatant from macrophage cultures after LPS induction for 24 hr in vitro 
(Figs. III-10-12). The levels of protein for all three cytokines secreted in the 
medium are significantly reduced at all dose levels, except for the IL-1a level 
found at the medium dose, which, although reduced, does not differ significantly 
from control values (see Fig. III-10). 
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Fig. III-10. Effect ofT -2 toxin on IL-Ia production. BIG-stimulated 
peritoneal macrophages (lx106/ml) from control and T-2 toxin-treated 
mice were activated with 10 J.Lg/ml LPS for 48 hrs. Interleukin-la 
in culture supernatants was detected by ELISA. Data were mean± S. E. 
(n=3). (*)Significant difference at 0.05 level between treatment and · 
control groups. 
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Fig. III-11. Effect of T-2 toxin on TNF production. BTG-stimulated 
peritoneal macrophages {lx106 /ml) from control and T-2 toxin-treated 
mice were activated with 10 ~/ml LPS for 48 hrs. Tumor necrosis 
factor in culture supernatants was detected by ELISA. Data were mean 
± S. E. (n=3). (*) Significant difference at 0.05 level between treatment and 
control groups. 
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Fig. III-12. Effect of T-2 toxin on IL-6 production. BIG-stimulated 
peritoneal macrophages (lx106 /ml) from control and T-2 toxin-treated 
mice were activated with 10 J.!g/ml LPS for 48 hrs. Interleukin-6 
in culture supernatants was detected by ELISA. Data were mean ± S. E. 
(n=3). (*)Significant difference at 0.05 level between treatment and · 
control groups. 
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Thus, T-2 toxin treatment in general seems to have a variable effect on IL-l 
a , TNF, and IL-6 mRNA, and to significantly decrease the amount of protein 
secreted into the medium at all dose levels. 
DISCUSSION 
This study measured the effect of T-2 toxin on the genetic expression of 
certain key cytokines and is based on the assumption that the analysis of the 
toxin-induced changes in the pattern of gene expression will help to elucidate the 
molecular mechanisms whereby the toxin exerts its immunosuppressive effects. 
Low and repeated doses of T-2 toxin were administered in vivo and both mRNA 
and protein levels of cytokines IL-2, IL-3, and IFNy in splenocytes, and cytokines 
IL-la, IL-6, and TNF in macrophages were measured after activation of the 
purified populations with Con A and LPS, respectively, in vitro. 
The high dose of T-2 toxin seems to be relatively more toxic; it increased 
both liver and spleen weights and RBC counts, and decreased the thymus 
weights significantly. Similar results were observed in other studies (Taylor et 
al., 1989; Dugyala et al., 1994). In addition, the relative spleen weights and WBC 
counts of medium-dose-treated animals increased significantly while at the same 
dose the thymus weights significantly decreased when compared to the control 
groups; this shows that T-2 toxin affects both the central and peripheral 
lymphoid organs studied. A decrease of thymus weights at all doses may be due 
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to cortical depletion (Taylor et al. , 1989). Balanced semipurified diet containing 
T-2 toxin (20 ppm) fed to mice for 6 weeks showed hyperplastic spleens (Hayes et 
al., 1980). The changes in the spleen were mainly in the red pulp involving 
proliferation of myeloid components, including erythroid and granulocytic 
precursors (Taylor et al., 1989). In the present study, the number of brewers 
thioglycolate broth-activated peritoneal macrophages collected in the high-dose-
treated mice was dramatically reduced (4-fold less than the controls). T-2 toxin is 
more toxic when given by the dietary route than when given by other routes in 
many species (Ohtsubo and Saito, 1977; Chi et al., 1977; Richard et al., 1978; 
Weaver et al., 1978; Hayes et al. , 1980). In these studies, T-2 toxin consistently 
caused reduced food consumption, reduced growth rates, and inflammatory 
lesions around the mouth and in the upper alimentary tract. Similar kinds of 
symptoms were observed in the present study. In one study (Taylor et al., 1989), 
the histopathalogy of male CD-1 mice treated with a high dose (2.5 mg/kg body 
wt) of T -2 toxin for 2 or 4 weeks included ulcers, partially calcified in the 
proximal portion of the cardia, with influx of mononuclear infiltration. The 
reduced number of peritoneal macrophages collected in the high-dose-treated 
groups in the present study may be due to their accretion in the inflammatory 
regions. Moreover, T-2 toxin has proven to be cytotoxic to many cell types 
(Gerberick and Sorenson, 1983; Holt et al., 1988a; Dugyala et al., 1994). T-2 toxin 
(0.1- 0.89 J.lM for 20 hr in vitro) decreased cell viability, cell number, and viability 
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index in alveolar macrophages of rats and showed pseudopodia, cellular 
blebbing, smoothing of membrane processes, and cell lys is when observed by 
scanning electronmicrosopy (Gerberick and Sorenson, 1983). 
There is general induction of IL-2 and IFNy mRNA levels in Con A-
activated splenocytes in vitro in all doses of T-2 toxin-treated mice; the values are 
significantly higher than controls in the low and high doses. For IL-3, mRNA 
levels are significantly higher than controls at the medium dose. It clearly shows 
tha t T-2 toxin directly or indirectly induces the mRNA levels of these cytokines 
either a t the transcriptional or post-transcriptional level. The protein levels of all 
three cytokines are also increased, significantly so for IL-2 and IFNy at low 
dosage, and for IL-3 at the low and medium dosages. There is a correspondence 
between mRNA and protein levels for IL-2 and IFNy in the low-dose-treated 
mice. This is an indication that at low dosage the toxin does not alter the usual 
transcriptional regulation of IL-2 and IFNy expression However, in the high-
dose-treated mice, protein levels for these cytokines do not correlate with the 
induced mRNA levels. One possible explanation is that T-2 toxin at the medium 
and high doses is superinducing mRNA levels by stabilizing the message for 
these cytokines while reducing the efficiency of translation or post-translational 
modification of the proteins. The pattern of protein expression for IL-3 does not 
correspond to the mRNA levels measured at any of the dosages of the toxin; 
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thus, for this cytokine, the usual transcriptional regulation is also affected by the 
toxin. 
CD4+ T cells are subdivided into two distinct subsets based on the pattern 
of lymphocyte secretion; TH1 cells produce IL-2 and IFNy (and other cytokines) 
but not IL-4, IL-5, IL-6, and IL-10. These cells are involved in cell-mediated 
immune responses. On the other hand, TH2 cells produce IL-4, IL-5, IL-6, and IL-
10, but not IL-2 and IFNy; they are involved in antibody-mediated immune 
responses. IL-3 is produced by both types of subsets (Mosmann and Coffman, 
1989). This division of labor among T-helper cells determines whether humoral 
or cell-mediated immunity will predominate following their first encounter with 
antigen. The high levels of IL-2 and IFNy measured after the low-dose treatment 
is an indication that, at that dosage, T-2 toxin may increase cell-mediated 
immunity. This does not necessarily translate into an enhanced immune 
response since, in order to be effective, these cytokines must interact with their 
target cells and these, in turn, may be impaired by other toxin-induced 
alterations, such as those found in the macrophages to be discussed below. 
It is known that these cytokines are tightly regulated both 
transcriptionally and post transcriptionally. Interleukin-2, IL-3, and IFNy 
cytokine genes share a consensus element, IT A TTT AT, located in the 3' 
untranslated region, which is believed to confer instability to the transcripts 
resulting in their rapid degradation (Campbell et a/., 1985; Caput et a/., 1986; 
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Shaw and Karmen, 1986). Cyclohexamide (CHX), a protein synthesis inhibitor, 
has been shown to superinduce IL-2 and IFNy mRNA. The superinduction is 
presumably due to stabilization of the mRNA because of CHX inhibition of 
RNase synthesis responsible for the specific degradation of the unstable 
transcripts (Cockfield and Ramassar, 1991; Zubiaga et al., 1991; Cockfield et al., 
1993). The observation that T-2 toxin increases mRNA levels of IL-2, IL-3 and 
IFNy and that it, in general, increases the levels of secreted protein in the 
medium suggests that its action resembles that of CHX. Vomitoxin, another 
trichothecene, produced by Fusarium graminearum, also superinduced the 
production of IL-2, IL-4, IL-5, and IL-6 mRNA and protein levels in EL4.1L-2 
thymoma cell line in vitro (Dong et al., 1994). A 4-fold increase in IL-2 levels was 
observed in Con A-activated splenocytes in vitro from mice dosed for four 
consecutive doses of 2 mg/ kg T-2 toxin (Holt et al., 1988b). Enhanced resistance 
to such infections as Listeria monocytogens due to preinoculation treatment with 
T-2 toxin in some studies (Carrier and Ziprin, 1986; Carrier et al., 1987) can be 
partially explained as being due either to the capacity of T-2 toxin to induce IL-2, 
IFNy, IL-3 and increase cell mediated immunity, or to an increase of phagocytic 
activity of macrophages. However, T-2 toxin immunotoxicity definitely depends 
on its dose and duration of exposure in the mice. T-2 toxin treatment (0-2.5 
mg/ kg) every third day in CD-1 mice for 2 weeks increased PHA-induced 
stimulation in vitro in splenocytes in low-dose-treatment groups and suppression 
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in high-dose-treatment groups in splenic lymphocytes, and no significant 
differences were observed when the treatment extended to 4 weeks (Taylor et al., 
1985). T-2 toxin is also known to decrease resistance to infections (Kanai and 
Kondo, 1984; Carrier and Ziprin, 1986) and cause a decrease in cell and humoral-
mediated immunity (Rosenstein et al., 1979; Taylor et al., 1985). Activation or no 
effect of the IL-2, IFNy, and IL-3 gene expression due to T-2 toxin exposure in the 
present study shows that T-2 toxin-induced immunosuppression may not be due 
to alteration of these cytokines, but some other mechanism. Thymic atrophy, 
depletion of T lymphocytes, and prolymphiod population in fetal thymocytes 
(Hayes et al., 1980; Hunter et al., 1985; Taylor et al., 1989; Holladay eta/., 1993; 
Holladay et al., 1995) due to the T-2 toxin exposure in mice shows that T-2 toxin 
is specifically lymphocytolytic. Even though elevated levels of cytokines are 
observed, lack of enough responding cells to the specific cytokines may cause 
immunosuppression. 
T-2 toxin seems to have a profound effect on the macrophage-produced 
cytokines when activated with LPS in vitro. As pointed out earlier in the 
discussion, there was a reduction in the number of macrophages in the high-
dose-treated groups, which may be due to the concentration of macrophages in 
the inflamatory sites, rather than their accumulation in the peritoneal fluid . The 
total mRNA was pooled and analyzed as a single group. This group of animals 
showed a slight decrease in the TNF mRNA when compared to the controls even 
120 
though the decrease cannot be evaluated statistically. In general, T-2 toxin does 
not seem to affect the mRNA levels of IL-1a, IL-6, and TNF but inhibits the 
secreted protein levels in all doses (IL-1a protein is not significantly decreased in 
the medium dose group). The data show that in the macrophage, the toxin 
regulates the expression of the cytokines measured mainly at the translational or 
post-translational level. 
T-2 toxin is known to be a protein synthesis inhibitor in immune cells 
(Gyongyossy-lssa and Khachatourians, 1984; Rosenstein and Lafarge-Frayssinet, 
1983). This inhibition may be due to direct action of the toxin on the protein 
synthesizing machinery of the cell, or it could be acting indirectly via some other 
pathway, i.e., the stress-related response involving the HPA axis. Evidence for a 
direct effect of the toxin on protein synthesis was obtained by Cundliffe et a/. 
(1974), who showed that T-2 toxin impairs polypeptide chain intiation by causing 
disaggregation of the polyribosomes. It is also known that trichothecenes, 
including T-2 toxin, bind to ribosomes and thereby inhibit peptidyl transferase 
and block intiation of polypeptide synthesis (Melmed and Yagen, 1985). Indirect 
action of T-2 toxin on the macrophage cytokine production is also substantiated . 
Endotoxemia is observed 24 hr after male CD-1 mice received a single oral dose 
of T-2 toxin (2.5-20 mg/ kg) coinciding with the increase of corticosterone levels 
(Taylor e( a/., 1989). Endotoxemia in male Swiss mice following treatment with 
T-2 toxin (4 mg/ kg) was found to be due to increased absorption of endotoxin, 
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an outer membrane component of gram-negative bacteria, from the 
gastrointestinal tract (Taylor et al., 1991). Even though they observed the 
increased levels of endotoxin and corticosterone levels in the higher 
concentration of the toxin, it is possible that these levels may also be increased in 
all doses used in this study. Corticosterone is known to selectively deplete the 
thymic cortical cells in mice (Carroll et al., 1969). This correlates with the 
significant decrease in thymic weights in all doses observed in this study, 
indicating that there is a hormonal imbalance due to a stress response associated 
with systemic endotoxemia. 
Endotoxin tolerance is the phenomenon developed by the host to survive 
and elicit controlled inflammatory responses due to a localized stimulus, 
resulting in repeated insult with the endotoxin (Zuckerman et al., 1991). It is 
possible that in the present study, peritonial macrophages became tolerant due to 
endotoxernia in vivo, thus becoming unable to secrete the cytokines upon further 
activation with LPS in vitro. Regulation of TNF expression in peritoneal 
macrophages that were refractory following repeated in vitro exposure to LPS 
has been demonstrated to occur at a post-translational level (Zuckerman et al., 
1989). Involvement of glucocorticoid hormones in this process has been shown 
(Beutler et al ., 1986). IL-l translation is also suppressed in LPS-activated U937 
cells in vitro when exogenous prostaglandins (PGE2) were added, via increase of 
cellular cAMP levels (Knudsen et al. , 1986). Endotoxin treatment is known to 
122 
increase PGE2 synthesis in monocytes (West eta/. , 1993). Corticotropin releasing 
factor induces not only the release of adrenocorticotropic hormone by the 
pituitary, which induces coticosterone via the HPA axis in adrenals, but also the 
release of catecholamines such as norepinephrine from adrenal medulla (Fuchs 
and Sanders, 1994). Norepinephrine seems to increase cAMP levels (Krammer, 
1988). It is possible that the 3' untranslated sequence (TT A TIT AT), which is 
conserved in pro-inflammatory cytokines (Brown and Beutler, 1990), may be 
regulated translationally through a cAMP-dependent signal transduction 
mechanism. 
In conclusion, T-2 toxin appears to affect cytokine production by 
lymphocytes and macrophages differentially. The lymphocyte-produced 
cytokine mRNA and protein levels are generally increased, and the macrophage-
produced cytokines are suppressed at the protein levels. The decrease in protein 
levels observed in the macrophage may be due to a direct effect of the toxin on 
the protein synthetic machinery of the cells, or an indirect response through a 
stress-related mechanism. The immunosuppression caused by the toxin may be 
due to the impairment of macrophage functions, or to the fact that, even in the 
presence of increased amounts of cytokine proteins (IL-2, IFNy, or IL-3), cytolytic 
action or impairment of membrane function by the toxin on effector cells, c.f., 
macrophages, cytotoxic/helper T cells, NK cells, etc., obviates the production of 
a full immune response. 
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SUMMARY 
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Mycotoxins are secondary fungal metabolites; they are ubiquitous in the 
environment and have a wide range of toxic effects, including immunotoxicity to 
humans as well as domestic and laboratory animals. Aflatoxin 81 is produced by 
several strains of aspergillus species and T-2 toxin is produced by the fusarium 
species. lmmunotoxicity of both toxins is mediated by their influence upon non-
specific immune processes such as adherence, phagocytosis, and chemotaxis by 
macrophages and other heterophils. Cell- and humoral-mediated immunity are 
modulated by affecting mainly T-helper cell functions. This would inhibit 
delayed-type hypersensitivity; cytotoxicity by NK, CTL, and macrophages; and 
T-dependent antibody production. Interestingly, many of the above mentioned 
immune functions are controlled by growth factors collectively known as 
cytokines. Little information is known about the modulation of cytokine gene 
expression by the mycotoxins, specifically, whether they influence their 
transcriptional and/ or translational regulation. 
The present study investigated the molecular events involved in AFBJ-
and T-2 toxin-induced immunotoxicity in male CD-1 mice by measuring gene 
expression of cytokines produced by peritoneal macrophages (IL-la, TNF, and 
IL-6) and lymphocytes (IL-2, IL-3, and IFNy). Messenger RNA and protein levels 
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were measured in LPS-activated macrophages and Con A-activated lymphocytes 
in vitro: Cytokine-specific mRNAs were identified and quantified by Northern 
blot/ RT-PCR techniques, and protein levels were measured by sandwich ELISA. 
Male CD-1 mice received either 0 (control), 0.03 (low dose), 0.145 (medium dose), 
and 0.7 (high dose) mg/kg body weight of AFB1 , or 0 (control), 0.1 (low dose), 0.5 
(medium dose), and 2.5 (high dose) mg/ kg body weight of T-2 toxin, by oral 
gavage every other day for 2 weeks (seven doses). 
The results clearly show that the toxicology and alteration of cytokine 
expression of AFB1 and T-2 toxin are entirely different. Aflatoxin B1 has no effect 
on the weights of the organs selected but does have a significant increase in the 
WBC count in the low-dose-treated group. T-2 toxin significantly suppressed the 
thymus weights in all groups, and increased the spleen weights in medium- and 
high-dose-treated groups. A significant increase of liver weight, and an increase 
of RBC counts in high dose and WBC counts in medium dose show that T-2 toxin 
affects some of the vital organs of the body. A 4-fold decrease in the total 
number of macrophages collected in high-dose-treated T-2 toxin group confirms 
that T-2 toxin is toxic in the high-dose-treated mice. 
Con A-induced production of cytokine profile from AFB1-treated mice 
splenocytes is different from the cytokines produced from T-2 toxin-treated mice. 
A significant decrease of IL-2 mRNA and a pattern of slight decrease in IFNy and 
IL-3 mRNA in the low-dose-treated AFB1 groups are observed. Protein levels of 
134 
these cytokines followed the pattern of mRNA of the respective cytokine; this 
shows that there is no decoupling of mRNA and protein synthesis. These results 
show that AFB1 did not have much effect on the expression of these cytokines. A 
slight decrease of these cytokines in the low dose-treated group may be due to 
the activation of inhibitory factors for T H 1-producing cytokines. 
T-2 toxin, on the other hand, induced the IL-2, IFNy, and IL-3 mRNA 
expression in in vitro Con A-activated splenocytes. Interleukin-2 and IFNy 
mRNA were induced significantly in high- and low-dose-treated mice, and IL-3 
mRNA is induced in medium-dose-treated mice. Protein levels of IL-2 and IFNy 
followed the mRNA levels in the low dose but not in the high dose. These 
results suggest that T-2 toxin is either increasing the transcription or stabilization 
of mRNA in the low- and high-dose-treated mice and at the same time 
interfering with the protein synthesis or secretion of these cytokines in the high-
dose-treated-mice. lnterleukin-3 protein levels are significantly high in the 
medium and low dose even though there is no significant increase in the mRNA 
levels in the low-dose-treated mice, suggesting that T-2 toxin also increases the 
translational or post-translational efficiency. These results also reveal that 
cytokines are modulated differentially by these toxins. 
Lipopolysaccharide-induced IL-la, TNF, and IL-6 gene expression in 
peritoneal macrophages is also modulated differently by both toxins in exposed 
mice. Messenger RNA expression of both IL-la and TNF was suppressed 
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significantly in high dose and increased significantly in low and medium dose, 
respectively, in AFB1-treated mice. Protein of both cytokines decreased 
significantly in accordance with the mRNA. lnterleukin-la protein is strongly 
suppressed also in low- and medium-dose-treated mice. lnterleukin-6 mRNA is 
increased significantly in the medium dose group and there is a general decrease 
the protein in all doses, which is significant in high-dose-treated groups. 
Aflatoxin B1 seems to modulate both mRNA and protein levels differently in all 
groups. Suppression or activation of mRNA levels by AFB1 may be due to 
modula tion of factors responsible for transcription or mRNA stability. Strong 
suppression of IL-la protein in all groups of treated mice is a very interesting 
result because of the unique mechanism of processing and secretion of IL-la 
when compared to the other pro-inflammatory cytokines. 
There are no significant differences in the mRNA levels of IL-la, TNF, 
and IL-6 in LPS-activated peritoneal macrophages of low- and medium-dose-
treated T-2 toxin mice. Significant levels could not be assessed statistically in the 
high-dose-treated group because pooled RNA from three animals is used as a 
single group due to lack of sufficient RNA. However, a slight decrease in TNF 
mRNA was observed with no difference in the other two cytokines in the high-
dose-treated mice. Protein levels in all cytokines are suppressed significantly 
(except IL"la in medium dose) in all treated doses; this shows that T-2 toxin has 
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more of an effect at the translational or post-translational level in a nonspecific 
manner. 
In short, AFB1 and T-2 toxin differ in the way they modulate cytokine 
expression in CD-1 mice. Based on these results and others, AFB1 may modulate 
the cell-mediated responses, inhibiting the macrophage-producing cytokines and 
other functions, thereby stopping the signals toT-helper cells. T-2-toxin-induced 
immunosuppression may also be due to the inhibition of cytokines produced by 
the macrophages, but lack of effector cells to respond to the cytokines (IL-2, IFN-
y, and IL-3) is also an important factor in the mechanism of immunosuppression 
of T-2 toxin. Figure IV-1 presents a summary based on the present data of the 
possible mechanisms through which AFB1 and T-2 toxin modulate cytokine gene 
expression. 
TNF ~ • ~ ____. cytotoxicity I r \..:/ phagocytosis ;;~Tm'~,An 
.. I f.:\ t ~ "lllllo... 
anh-vira ,_ ..._.____ ~ IL-l macrophage IL-l 
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Fig. IV-1. The proposed mechanism of action of AFBifT-2 toxin on cytokine communication 
network in male CD-1 mice. 
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